PRE 14A
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
þ Preliminary Proxy Statement
o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material Pursuant to §240.14A-12
NET 1 UEPS TECHNOLOGIES, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
þ |
|
No fee required. |
|
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
(1) |
|
Title of each class of securities to which transaction applies:
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies:
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the
amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction:
|
|
|
(5) |
|
Total fee paid:
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule
and the date of its filing. |
|
|
(1) |
|
Amount previously paid:
|
|
|
(2) |
|
Form, schedule or registration statement no.:
|
|
|
(3) |
|
Filing party:
|
|
|
(4) |
|
Date filed:
|
NET 1 UEPS TECHNOLOGIES, INC.
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
to be held on November 27, 2008
To the Shareholders of Net 1 UEPS Technologies, Inc.:
NOTICE IS HEREBY GIVEN that the 2008 Annual Meeting of Shareholders of Net 1 UEPS
Technologies, Inc., a Florida corporation, will be held at President Place, 6th Floor, Cnr. Jan
Smuts Avenue and Bolton Road, Rosebank, Johannesburg, South Africa on November 27, 2008 at 17h00,
local time, for the following purposes:
|
1. |
|
To elect seven directors to serve until the next Annual Meeting of Shareholders and
until their successors are duly elected and qualified. |
|
|
2. |
|
To consider a proposal to amend and restate our Articles of Incorporation to (i)
increase the number of authorized shares of our common stock from 83,333,333 shares to
200,000,000 shares, (ii) simplify our Articles of Incorporation by deleting obsolete
provisions and (iii) consolidate our Articles of Incorporation so that the entire charter
will be contained in one document. |
|
|
3. |
|
To ratify the selection of Deloitte & Touche (South Africa) as the independent registered
public accounting firm for the fiscal year ending June 30, 2009. |
|
|
4. |
|
To transact such other business and act upon any other matter which may properly come
before the annual meeting or any adjournment or postponement of the meeting. |
Our Board of Directors has fixed the close of business on October 17, 2008 as the record date
for determining shareholders entitled to notice of and to vote at the meeting. A list of the
shareholders as of the record date will be available for inspection by shareholders at our
principal executive offices, which is located at President Place, 6th Floor, Cnr. Jan Smuts Avenue
and Bolton Road, Rosebank, Johannesburg, South Africa during business hours for a period of ten
days prior to the meeting.
Your attention is directed to our annual report for the fiscal year ended June 30, 2008, which
is enclosed with this proxy statement.
|
|
|
|
|
|
The Board of Directors,
|
|
|
/s/ Dr. Serge Belamant
|
|
|
Dr. Serge C. P. Belamant |
|
|
Chairman and Chief Executive Officer |
|
|
Johannesburg, South Africa
October 29, 2008
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE MEETING OF SHAREHOLDERS TO
BE HELD ON NOVEMBER 27, 2008. A complete set of proxy materials relating to our annual meeting is
available on the Internet. These materials, consisting of the Notice of Annual Meeting and Proxy
Statement, including proxy card and annual report, may be viewed and downloaded at
http://materials.proxyvote.com/64107N
WE CORDIALLY INVITE ALL SHAREHOLDERS TO ATTEND IN PERSON. HOWEVER, REGARDLESS OF WHETHER YOU
PLAN TO ATTEND THE ANNUAL MEETING, PLEASE
PROMPTLY COMPLETE, SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD IN THE ENVELOPE PROVIDED. IF
YOU ATTEND THE ANNUAL MEETING YOU MAY REVOKE YOUR
PROXY CARD AND VOTE IN PERSON.
NET 1 UEPS TECHNOLOGIES, INC.
President Place, 6th Floor, Cnr. Jan Smuts Avenue and Bolton Road
Rosebank, Johannesburg, South Africa
PROXY STATEMENT
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page |
|
|
|
|
|
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
3 |
|
|
|
|
7 |
|
|
|
|
9 |
|
|
|
|
9 |
|
|
|
|
9 |
|
|
|
|
10 |
|
|
|
|
12 |
|
|
|
|
12 |
|
|
|
|
13 |
|
|
|
|
13 |
|
|
|
|
13 |
|
|
|
|
14 |
|
|
|
|
15 |
|
|
|
|
15 |
|
|
|
|
21 |
|
|
|
|
22 |
|
|
|
|
23 |
|
|
|
|
24 |
|
|
|
|
25 |
|
|
|
|
25 |
|
|
|
|
25 |
|
|
|
|
26 |
|
|
|
|
27 |
|
|
|
|
28 |
|
|
|
|
30 |
|
General
This proxy statement is being furnished to shareholders of Net 1 UEPS Technologies, Inc., a
Florida corporation, in connection with the solicitation by our Board of Directors, or the Board,
of proxies for use at the Annual Meeting of Shareholders to be held at President Place, 6th Floor,
Cnr. Jan Smuts Avenue and Bolton Road, Rosebank, Johannesburg, South Africa on November 27, 2008 at
17h00, local time, and at any adjournment or postponement of the annual meeting.
Page 1
INFORMATION CONCERNING SOLICITATION AND VOTING
Solicitation
We will bear the entire cost of the solicitation, including the preparation, assembly,
printing and mailing of this proxy statement, including the proxy card and any additional
solicitation materials furnished to our shareholders. Copies of solicitation materials will be
furnished to brokerage houses, fiduciaries and custodians holding shares in their names that are
beneficially owned by others so that they may forward this solicitation material to such beneficial
owners. We may reimburse these persons for their reasonable expenses in forwarding solicitation
materials to beneficial owners. The original solicitation of proxies by mail may be supplemented by
a solicitation by personal contacts, telephone, facsimile, electronic mail or any other means by
our directors, officers or employees. No additional compensation will be paid to our directors,
officers or employees for performing these services. Except as described above, we do not presently
intend to solicit proxies other than by mail.
This proxy statement and the accompanying solicitation materials are being sent to our
shareholders on or about October 29, 2008.
Revocation of Proxies
You may revoke your proxy at any time prior to exercise of the proxy by (1) delivering a
written notice of revocation or a duly executed proxy with a later date by mail to our corporate
secretary at Net 1 UEPS Technologies, Inc., P O Box 2424, Parklands 2121, Gauteng, South Africa, or
(2) attending the meeting and voting in person. If you hold shares through a bank or brokerage
firm, you must contact that firm to revoke any prior voting instructions. However, if you are a
shareholder whose shares are not registered in your own name, you will need documentation from your
record holder stating your ownership as of October 17, 2008 in order to vote personally at the
annual meeting.
Record Date, Quorum and Voting Requirements
Each holder of shares of our common stock on the close of business on October 17, 2008, the
record date, is entitled to notice of and vote at the annual meeting or any adjournment thereof.
There were 58,399,595 shares of common stock outstanding on the record date. The presence at the
annual meeting, in person or by a proxy, of a majority of the total number of outstanding shares of
common stock, or 29,199,798 shares, is necessary to constitute a quorum. Each share of common stock
is entitled to one vote on all matters to be acted upon at the annual meeting. For purposes of the
quorum and the discussion below regarding the vote necessary to take shareholder action, holders of
record of common stock who are present at the annual meeting in person or by proxy and who abstain,
including brokers holding customers shares of record who cause abstentions to be recorded at the
annual meeting, are considered shareholders who are present and entitled to vote and they count
toward the quorum. In the event that there are not sufficient votes for a quorum or to approve any
proposal at the annual meeting, the annual meeting may be adjourned in order to permit the further
solicitation of proxies.
Brokers holding shares of record for customers generally are not entitled to vote on certain
matters unless they receive voting instructions from their customers. Broker non-votes mean the
votes that could have been cast on the matter in question if the brokers had received instructions
from their customers, and as to which the brokers have notified us on a proxy form in accordance
with industry practice or have otherwise advised us that they lack voting authority.
Under the rules that govern brokers who are voting with respect to shares held in a fiduciary
capacity, brokers have the discretion to vote shares on routine matters, but not on non-routine
matters. Routine
Page 2
matters include, among other things, the election of directors in an uncontested election,
ratification of the appointment of an independent registered public accounting firm and an increase
in the number of authorized shares of common stock if, as in our case, there are no specific plans
for the increased number of shares. This means that if you hold your shares through a broker, bank
or other nominee, and you do not provide voting instructions by the tenth day before the annual
meeting, the broker, bank or other nominee has the discretion to vote your shares on all proposals
described in this proxy statement
All outstanding shares of common stock represented by valid and unrevoked proxies received in
time for the annual meeting will be voted. Shares will be voted as instructed in the accompanying
proxy on each matter submitted to shareholders. A shareholder may, with respect to the election of
directors (1) vote for the election of the named director nominees, (2) withhold authority to vote
for all such director nominees or (3) vote for the election of all such director nominees other
than any nominee(s) with respect to whom the shareholder withholds authority to vote by writing
such nominees name on the proxy in the space provided. A shareholder may, with respect to each
other matter specified in the notice of meeting (1) vote FOR the matter, (2) vote AGAINST the
matter or (3) ABSTAIN from voting on the matter. If no instructions are given on a properly
completed and returned proxy, the shares will be voted FOR the election of the named director
nominees, FOR the approval of the Amended and Restated Articles of Incorporation and FOR the
ratification of the selection of Deloitte & Touche (South Africa), or Deloitte, as our independent
registered public accounting firm for the fiscal year ending June 30, 2009.
Our seven nominees will be elected by a plurality of votes. Withholding a vote as to any
nominee is the equivalent of abstaining. In an uncontested election such as this, abstentions have
no effect, since approval by a specific percentage of the shares present or outstanding is not
required. With respect to the proposals relating to the approval of the Amended and Restated
Articles of Incorporation and the ratification of the selection of Deloitte as our independent
registered public accounting firm, the proposals will be approved if the votes cast in favor of the
applicable proposal exceed the number of votes cast against the proposal, and abstentions and
broker non-votes will not be taken into account in determining the outcome of the vote on these
proposals.
The Board knows of no additional matters that will be presented for consideration at the
annual meeting. Return of a valid proxy, however, confers on the designated proxy holders the
discretionary authority to vote the shares in accordance with their best judgment on such other
business, if any, that may properly come before the meeting or any adjournment or postponement
thereof. Proxies solicited hereby will be tabulated by inspectors of election designated by the
Board.
PROPOSALS TO BE VOTED ON AT THE ANNUAL MEETING
PROPOSAL NO. 1: ELECTION OF DIRECTORS
The terms of office of each of our current directors will expire at the annual meeting or at
such time as their successors shall be elected and qualified. The Board has determined to nominate
for re-election each of our current directors (see Information Regarding the Nominees for
information on all directors) for a one-year term expiring at the annual meeting of shareholders in
2009 or until their successors shall be duly elected and qualified.
The persons named in the enclosed proxy intend to vote properly executed and returned proxies
FOR the election of all nominees proposed by the Board unless authority to vote is withheld. In the
event that any nominee is unable or unwilling to serve, the persons named in the proxy will vote
for such substitute nominee or nominees as they, in their discretion, shall determine. The Board
has no reason to believe that any nominee named herein will be unable or unwilling to serve.
Page 3
The Board recommends that you vote FOR election of each of its director nominees.
Information Regarding the Nominees
The current members of our Board are as follows:
|
|
|
Dr. Serge C.P. Belamant
55 years old
Director since 1997
Chairman and Chief
Executive Officer
|
|
Dr. Serge C.P. Belamant has been our chief
executive officer since October 2000 and the
chairman of our Board since February 2003. From
June 1997 until June 2004, Dr. Belamant served as
chief executive officer and a director of Net 1
Applied Technology Holdings, or Aplitec, whose
business was acquired by Net 1 in June 2004. From
1996 to 1997, Dr. Belamant served as a consultant
in the development of Chip Off-Line Pre-Authorized
Card, which is a Visa product. From October 1989
to September 1995, Dr. Belamant served as the
managing director of Net 1 (Pty) Limited, a
privately owned South African company specializing
in the development of advanced technologies in the
field of transaction processing and payment
systems. Dr. Belamant also serves on the boards of
a number of other companies that perform welfare
distribution services and the provision of
microfinance to customers. Dr. Belamant spent ten
years working as a computer scientist for Control
Data Corporation where he won a number of
international awards. Later, he was responsible
for the design, development, implementation and
operation of the Saswitch ATM network in South
Africa that rates today as the third largest ATM
switching system in the world. Dr. Belamant has
patented a number of inventions besides the FTS
patent ranging from biometrics to gaming-related
inventions. Dr. Belamant has more than 28 years of
experience in the fields of operations research,
security, biometrics, artificial intelligence and
online and offline transaction processing systems.
Dr. Belamant holds a PhD in Information Technology
and Management. |
Page 4
|
|
|
Herman Gideon Kotzé
39 years old
Director since 2004
Chief Financial Officer,
Secretary and Treasurer
|
|
Herman Gideon Kotzé has been our chief
financial officer, secretary and treasurer
since June 2004. From January 2000 until June
2004, he served on the board of Aplitec as
group financial director. In mid-1997 until
October 1998, Mr. Kotzé worked for the
Industrial Development Corporation of South
Africa Limited as a business analyst. Mr. Kotzé
served his articles from 1994 to 1996 at KPMG
in Pretoria, South Africa, and in 1997 he
became the audit manager for several major
corporations in the manufacturing, mining,
retail and financial services industries. Mr.
Kotzé joined Aplitec in November 1998 as a
strategic financial analyst. Mr. Kotzé is a
member of the South African Institute of
Chartered Accountants. |
|
|
|
Christopher Stefan
Seabrooke
55 years old
Director since 2005
Chief Executive Officer of
Sabvest Limited
|
|
Christopher Stefan Seabrooke has been a member
of our Board since January 2005. Mr. Seabrooke
has served on the board of directors of over
twenty listed companies. Mr. Seabrooke is
currently on the board of directors of the
following five other JSE Limited listed
companies chief executive officer of Sabvest
Limited, a finance and investment group,
non-executive chairman of Metrofile Holdings
Limited and Setpoint Technology Holdings
Limited, non-executive deputy chairman of
Massmart Holdings Limited and a non-executive
director of Datatec Limited, which is also
listed on AIM in the United Kingdom, or UK. Mr.
Seabrooke is a member of The Institute of
Directors in South Africa. Formerly, he was the
chairman of the South African State Theater and
the deputy chairman of each of the National
Arts Council and the Board of Business and Arts
South Africa. Mr. Seabrooke has degrees in
Economics and Accounting from the University of
Natal and an MBA from the University of
Witwatersrand. |
|
|
|
Antony Charles Ball
49 years old
Director since 2004
Chief Executive Officer of
Brait Group
|
|
Antony Charles Ball has been a member of our
Board since June 2004. Mr. Ball has held
various senior leadership positions with the
Brait Group, or Brait, since 1998 and has been
the chief executive officer of Brait since
October 1, 2006. Mr. Ball has led the raising
and governance of a number of Braits private
equity funds and is responsible for certain of
its private equity investments. Prior to
assuming his current position at Brait, Mr.
Ball served as joint deputy chairman of Brait
from 1998 to March 2000. Prior to joining
Brait, Mr. Ball was the chief executive of
Capital Partners, which was the predecessor
company to Brait and which pioneered the
private equity market in South Africa, from
1991 to 1998. Mr. Ball began his career with
Deloitte & Touche Consulting (1986-1991), where
he co-founded its Strategy Group. Mr. Ball is a
member of the board of Brait S.A. and its
subsidiaries. Mr. Ball has been designated as a
director by South African Private Equity Fund
III, L.P., an affiliate of Brait, or SAPEF,
pursuant to a contractual arrangement. |
Page 5
|
|
|
Alasdair J. K. Pein
48 years old
Director since 2005
Director of Southern Cross
Capital UK Limited
|
|
Alasdair Jonathan Kemsley Pein has been a
member of our Board since February 2005. Mr.
Pein is a director of Southern Cross Capital
UK Limited, which manages investment funds
for Brenthurst Limited, an investment holding
company for the Oppenheimer family interests.
From 1994 until 2002, Mr. Pein was President
and CEO of Task (USA), Inc., a New York-based investment company. Mr. Pein also
serves as a director of Arsenal Digital
Solutions, a privately-held U.S. company that
provides on-demand data protection services.
Between 1989 and 1994, Mr. Pein worked in
London for Bankers Trust International
mergers and acquisitions team and then at
Gilbert Elliot Corporate Finance. Mr. Pein
is a qualified South African chartered
accountant and completed his articles with
Deloitte in Johannesburg in 1987. Mr. Pein
has been designated as a director by SAPEF
pursuant to a contractual arrangement. |
|
|
|
Paul Edwards
54 years old
Director since 2005
Executive Chairman of
Merryn Capital
|
|
Paul Edwards has been a member of our Board
since July 2005. Mr. Edwards is the
executive chairman of Merryn Capital, a
privately-owned financial services group.
From 2002 to 2005, Mr. Edwards was executive
chairman of Chartwell Capital Group. In
January 2005, Mr. Edwards was appointed
non-executive chairman of Starcomms Limited,
a Nigerian telecommunications operator.
Prior to that, Mr. Edwards was the chief
executive officer of MTN Group, a pan-African
mobile operator. Between 1999 and 2001, Mr.
Edwards was the chief executive officer of
the Johnnic Group in South Africa, of which
the MTN Group was a subsidiary. Between 1995
and 1999, Mr. Edwards was the chief operating
officer of MEASAT Broadcast Network, a
Malaysian-based regional pay television
operator. Between 1993 and 1995, Mr. Edwards
was executive vice president of satellite
television broadcaster Star TV, based out of
Hong Kong. Between 1989 and 1993, Mr. Edwards
was chief executive officer of Multichoice,
Africas leading pay television operator.
Mr. Edwards has a BSc and an MBA from the
University of Cape Town. |
|
|
|
Tom C. Tinsley
55 years old
Director since 2008
Director of General Atlantic
LLC
|
|
Tom C. Tinsley has been a member of our Board
since September 2008. He has been employed by
General Atlantic LLC, or GA, since 1999 and
currently serves as a managing director of
GA. Mr. Tinsley has served on numerous boards
of directors of both private and public
companies in the United States. Prior to
joining GA, he served as Chairman and Chief
Executive of the management board of Baan
Company NV, a leading provider of enterprise
software solutions. Prior to joining Baan
Company NV, he was a director at McKinsey &
Company, where he was employed for 18 years.
Mr. Tinsley serves on our Board as the
nominated director pursuant to a contractual
arrangement between us and investment
entities affiliated with GA pursuant to which
GA is entitled to designate one person to
serve on our Board. Mr. Tinsley replaced Mr.
Florian P. Wendelstadt as the GA designee.
Mr. Tinsley received a MBA from The Stanford
Graduate School of Business in 1978. |
Page 6
PROPOSAL NO. 2: APPROVAL OF THE AMENDMENT AND RESTATEMENT OF OUR ARTICLES OF INCORPORATION
DESCRIPTION OF THE AMENDMENT AND RESTATEMENT OF OUR ARTICLES OF INCORPORATION
Our Board of Directors has unanimously adopted a resolution, subject to shareholder approval,
approving an Amendment and Restatement of our Articles of Incorporation (the Amendment and
Restatement) to (i) increase the number of authorized shares of our common stock from 83,333,333
shares to 200,000,000 shares, (ii) simplify our Articles of Incorporation by deleting obsolete
provisions as more fully described below and (iii) consolidate our Articles of Incorporation so
that the entire charter will be contained in one document. No change is being proposed to the
number of authorized shares of our preferred stock.
A
copy of the proposed Amendment and Restatement is attached as
Exhibit A to this Proxy
Statement.
REASONS FOR AND EFFECT OF THE AMENDMENT AND RESTATEMENT OF OUR ARTICLES OF INCORPORATION
Additional Authorized Shares of Common Stock
The maximum number of shares that our Articles of Incorporation currently authorize the
Company to issue and have outstanding at any one time is 133,333,333, of which 83,333,333 shares
are designated as common stock, par value $0.001 and 50,000,000 shares are designated as preferred
stock, par value $0.001. As of October 17, 2008, 58,399,595 shares of our common stock were
outstanding, 1,463,372 shares were reserved for issuance upon exercise of outstanding stock
options, 1,143,886 shares remained available for future awards under our Amended and Restated 2004
Stock Incentive Plan, or the Stock Incentive Plan. The proposed amendment to increase the number of
authorized shares of our common stock will provide us with the flexibility to issue additional
shares of common stock for various corporate purposes as the need arises from time to time, such as
to make potential acquisitions, to effect one or more financings through the issuance of equity or
equity-linked securities, to increase the number of shares available for issuance under our Stock
Incentive Plan or to effect stock splits or stock dividends.
If the proposal is approved, our Board will be empowered to authorize the issuance of
additional shares of common stock, at such times and for such consideration as it deems
appropriate, subject to applicable law and to the rules of The Nasdaq Stock Market which require
shareholder approval of share issuances under certain circumstances. However, our Board believes
that having such flexibility is in the best interests of the Company and our shareholders because
it will enable us to take advantage of market conditions and the availability of favorable
opportunities without the delay and expense associated with holding a special meeting of
shareholders to authorize additional shares that could be required to effect any particular
transaction.
Issuance by us of any additional shares of common stock would have a dilutive effect on the
voting power, on a percentage basis, of existing shareholders. Furthermore, such issuance could
also dilute our earnings per share, depending upon the number of shares issued and the
consideration received by us in the transaction. The newly authorized shares of common stock will
have voting and other rights identical to those of the currently authorized shares of common stock.
The increased number of authorized and unissued shares could also, in certain circumstances,
have an anti-takeover effect. For example, it would permit issuances that could substantially
dilute the stock ownership of a person seeking to effect a change in the composition of our Board
or contemplating a
Page 7
tender offer or other business combination transaction with the Company. However, our current
Articles of Incorporation already authorize blank check preferred stock which permits such
issuances and the share increase is not being proposed in response to any effort by a third party
of which we are aware to accumulate shares of our common stock or obtain control of the Company,
nor is it part of a plan to recommend to the shareholders a series of provisions to address
takeover concerns. Other than the share increase proposal, our Board does not currently contemplate
recommending the adoption of any other amendments to our Articles of Incorporation that it believes
would affect the ability of third parties to take over or change the control of the Company. Other
than for issuances pursuant to our awards made under our Stock Incentive Plan, we have no current
plans to issue any additional shares of our common stock.
Deletion of obsolete provisions
Our current Articles of Incorporation contain numerous provisions which are obsolete. In
particular, most of our current Articles of Incorporation concerns the authorization, designation,
preferences, rights and qualifications, limitations and restrictions of our special convertible
preference stock. On October 3, 2008, we received approval for the listing of our common stock on
the JSE Limited and such listing commenced on October 8, 2008. As a result of such listing, all of
our issued and outstanding special convertible preference shares were converted into shares of our
common stock. Because no special convertible preference stock is currently issued and no shares of
such stock will be reissued, we are proposing to delete all of the provisions pertaining to the
special convertible preference stock.
Other obsolete provisions currently contained in our Articles of Incorporation include: (i)
the name of our original incorporator; (ii) the initial principal office and mailing address; (iii)
the initial registered agent and registered office in the State of Florida and (iv) the number of
our initial directors and the names and addresses of our initial directors. Florida law provides
that such provisions, which are solely of historic interest, may be deleted from our Articles of
Incorporation. Accordingly, because these obsolete provisions are no longer relevant to the
Company, we are proposing to delete them from our Articles of Incorporation.
We are also proposing the Amendment and Restatement to delete the provision in our current
Articles of Incorporation which provides that we may indemnify our directors, officers, employees
and agents, as such provision is not required to be contained in our Articles of Incorporation and
the provision of indemnification for our directors, officers, employees and agents is more fully
addressed in our bylaws.
Restatement
Since our incorporation in 1997, we have amended our Articles of Incorporation on two separate
occasions. The first amendment was filed in May 2004 and the second amendment was filed in June
2005. Consequently, our Articles of Incorporation currently consist of three separate documents
which can be difficult to read as a comprehensive document.
Thus, for ease of reference, we are proposing to restate our current Articles of Incorporation
to consolidate our charter into one unified document that contains only currently relevant
provisions.
PROCEDURE FOR AMENDING AND RESTATING THE ARTICLES OF INCORPORATION
In the event that shareholder approval of the Amendment and Restatement is obtained, we intend
to file the proposed Amendment and Restatement as well as the requisite Certificate Accompanying
Articles of Restatement of Articles of Incorporation with the Secretary of State of the State of
Florida as
Page 8
soon as practicable after the date of the annual meeting. The Amendment and Restatement will become
effective upon such filing.
The Certificate Accompanying Articles of Restatement of Articles of Incorporation containing a
copy of the Amendment and Restatement is set forth in
Exhibit A to this Proxy Statement (and is
subject to modification to include such changes as may be required by the office of the Secretary
of State of the State of Florida and as the Board of Directors deems necessary and advisable to
effect the amendments described above).
The Board recommends that you vote FOR the amendment and restatement of our Articles of
Incorporation.
PROPOSAL NO. 3: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee of our Board has proposed that Deloitte be selected to serve as
independent registered public accounting firm for the fiscal year ending June 30, 2009. A
representative of Deloitte is expected to be present at the annual meeting. Such representative
will have an opportunity to make a statement if he or she desires to do so and is expected to be
available to respond to appropriate questions from shareholders. Deloitte currently serves as our
independent registered public accounting firm.
We are asking our shareholders to ratify the selection of Deloitte as our independent
registered public accounting firm. Although ratification is not required by our by-laws or
otherwise, the Board is submitting the selection of Deloitte to our shareholders for ratification
as a matter of good corporate practice. In the event our shareholders fail to ratify the
appointment, the Audit Committee may reconsider this appointment. Even if the selection is
ratified, the Audit Committee in its discretion may select a different registered public accounting
firm at any time during the year if it determines that such a change would be in our best interests
and the best interests of our shareholders.
The Board recommends a vote FOR ratification of Deloitte.
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
MEETINGS OF THE BOARD AND DIRECTOR INDEPENDENCE
Our Board typically holds a regular meeting once every quarter and holds special meetings when
necessary. During the fiscal year ended June 30, 2008, our Board held a total of six meetings. All
of the directors who served during our 2008 fiscal year attended or participated in more than 75%
of the aggregate number of meetings of the Board and meetings of those committees of the Board on
which such director served during the year. We encourage each member of the Board to attend the
annual meeting of shareholders, but have not adopted a formal policy with respect to such
attendance. Five of our directors who served during fiscal 2008 attended last years annual
meeting. The non-management directors meet regularly without any management directors or employees
present. These meetings are held on the same day as the audit committee or Board meetings and the
chairperson of these meetings is currently Mr. Seabrooke.
The Board annually examines the relationships between the Company and each of its directors.
After this examination, the Board has concluded that Messrs. Seabrooke, Pein, Edwards and Tinsley
are independent as defined under Nasdaq Rule 4350(c) and under Rule 10A-3(b)(1) under the
Securities Exchange Act of 1934, or the Exchange Act, as that term relates to membership on the
Board and the various Board committees. Mr. Ball is an independent director as defined under
Nasdaq rules but is not eligible to serve on our Audit Committee, under Rule 10A-3(b)(1).
Page 9
COMMITTEES OF THE BOARD
The Board has established an Audit Committee, a Remuneration Committee and a Nominating and
Corporate Governance Committee. The members of our Board Committees are presented in the table
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominating and |
|
|
|
|
|
|
|
|
|
|
Corporate |
|
|
Audit |
|
Remuneration |
|
Governance |
Director |
|
Committee |
|
Committee |
|
Committee |
Antony C. Ball |
|
|
|
|
|
|
X |
|
|
|
X |
|
Dr. Serge C.P. Belamant (#) |
|
|
|
|
|
|
|
|
|
|
|
|
Paul Edwards |
|
|
X |
|
|
|
X |
|
|
|
X |
|
Herman G. Kotzé (#) |
|
|
|
|
|
|
|
|
|
|
|
|
Alasdair J.K. Pein |
|
|
X |
|
|
|
X |
* |
|
|
X |
|
Christopher S. Seabrooke |
|
|
X |
* |
|
|
X |
|
|
|
X |
* |
Tom C. Tinsley |
|
|
|
|
|
|
X |
|
|
|
X |
|
|
|
|
# |
|
Executive |
|
* |
|
Chairperson |
Audit Committee
The Audit Committee consists of Messrs. Seabrooke, Pein and Edwards, with Mr. Seabrooke acting
as the chairperson. The Board has determined that Mr. Seabrooke is an audit committee financial
expert as that term is defined in applicable Securities and Exchange Commission, or SEC, rules,
and that all three members meet Nasdaqs financial literacy criteria. The Audit Committee held nine
meetings during the 2008 fiscal year. See Audit Committee Report on page 27.
The Audit Committee was established by the Board for the primary purpose of overseeing or
assisting the Board in overseeing the following:
|
|
|
the integrity of our financial statements; |
|
|
|
|
our compliance with legal and regulatory requirements; |
|
|
|
|
the qualifications and independence of our registered public accounting
firm; |
|
|
|
|
the performance of our independent auditors and of the internal audit
function; |
|
|
|
|
the accounting and financial reporting processes and the audits of our financial
statements; and |
|
|
|
|
our systems of disclosure controls and procedures, internal controls over financial
reporting, and compliance with ethical standards adopted by us. |
The Audit Committee operates under a written charter that was last revised in August 2008. A
copy of the current charter is attached as Appendix A hereto and is available without charge on our
website, www.net1ueps.com under the Financial Info Corporate Governance section.
Page 10
Remuneration Committee
During the 2008 fiscal year, the Remuneration Committee comprised Messrs. Pein, Seabrooke,
Edwards, Wendelstadt (who was replaced by Mr. Tinsley in September 2008) and Ball, with Mr. Pein
acting as the chairperson. The Remuneration Committee held four meetings during the 2008 fiscal
year. The Remuneration Committee has the following principal responsibilities, authority and
duties:
|
|
|
review and approve performance goals and objectives relevant to the
compensation of all our executive officers, evaluate the performance of each
executive officer in light of those goals and objectives, and set each executive
officers compensation, including incentive-based and equity-based compensation,
based on such evaluation; |
|
|
|
|
make recommendations to the Board with respect to incentive and equity-based
compensation plans; |
|
|
|
|
review and make recommendations to the Board regarding compensation-related
matters outside the ordinary course, including but not limited to employment
contracts, change-in-control provisions and severance arrangements; |
|
|
|
|
administer our stock option, stock incentive, and other stock compensation
plans, including the function of making and approving all grants of options and
other awards to all executive officers and directors, and all other eligible
individuals, under such plans; |
|
|
|
|
review annually and make recommendations to the Board regarding director
compensation; |
|
|
|
|
assist management in developing and, when appropriate, recommend to the Board,
the design of compensation policies and plans; |
|
|
|
|
review and discuss with management the disclosures in our Compensation
Discussion and Analysis and any other disclosures regarding executive
compensation to be included in our public filings or shareholder reports; and |
|
|
|
|
recommend to the Board whether the Compensation Discussion and Analysis should
be included in our proxy statement, Form
10-K, or information statement, as
applicable, and prepare the related report required by the rules of the SEC. |
The Remuneration Committee operates under a written charter that was last revised in August
2008. A copy of the current charter is attached as Appendix B hereto and is available without
charge on our website, www.net1ueps.com under the Financial Info Corporate Governance section.
Nominating and Corporate Governance Committee
During the 2008 fiscal year, the Nominating and Corporate Governance Committee comprised
Messrs. Seabrooke, Ball, Pein, Edwards and Wendelstadt (who was replaced by Mr. Tinsley in
September 2008), with Mr. Seabrooke acting as the chairperson. The Nominating and Corporate
Governance Committee held four meetings during the 2008 fiscal year. The principal duties and
responsibilities of the Nominating and Corporate Governance Committee are as follows:
Page 11
|
|
|
monitor the composition, size and independence of the Board; |
|
|
|
|
establish criteria for Board and committee membership and recommend to our Board
proposed nominees for election to the Board and for membership on each committee of
the Board; |
|
|
|
|
monitor our procedures for the receipt and consideration of director nominations
by shareholders and other persons and for the receipt of shareholder communications
directed to our Board; |
|
|
|
|
make recommendations regarding proposals submitted by our shareholders; |
|
|
|
|
establish and monitor procedures by which the Board will conduct, at least
annually, evaluations of its performance; |
|
|
|
|
review our Corporate Governance
Guidelines annually and recommend changes, as appropriate, for review and approval
by the Board; and |
|
|
|
|
make recommendations to the Board regarding management succession planning and
corporate governance best practices. |
The Nominating and Corporate Governance Committee operates under a written charter that was
last revised in August 2008. A copy of the current charter is attached as Appendix C hereto and is
available without charge on our website, www.net1ueps.com under the Financial Info Corporate
Governance section.
REMUNERATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
During the fiscal year 2008, our Remuneration Committee consisted of Messrs. Alasdair J. K.
Pein, the committees chairperson, Christopher S. Seabrooke, Florian P. Wendelstadt (who was
replaced by Mr. Tinsley in September 2008), Paul Edwards and Antony C. Ball. None of the members
of our Remuneration Committee has at any time been one of our officers or employees. None of our
executive officers serves or in the past has served as a member of the Board or remuneration
committee of any entity that has one or more of its executive officers serving on our Board or our
Remuneration Committee.
Pursuant to the common stock purchase agreement, dated January 30, 2004, between us and SAPEF,
SAPEF is entitled to designate three nominees to our Board. SAPEF informally agreed to reduce the
number of its designated nominees from three to two due to the reduction in the number of our
shares that SAPEF holds. Mr. Ball and Mr. Pein currently serve on our Board as SAPEFs designees.
Pursuant to the stock purchase agreement, dated July 18, 2005, among the investment entities
affiliated with GA, us and certain other parties, GA is entitled to designate one nominee to our
Board. During the fiscal year 2008, Mr. Wendelstadt served as the GA designee. The GA designee is
currently Mr. Tinsley. In addition, pursuant to the stock purchase agreement, we granted rights,
under certain circumstances and subject to certain limitations, with respect to the registration of
our shares held by investment entities affiliated with GA.
NOMINATIONS PROCESS AND DIRECTOR QUALIFICATIONS
The Nominating and Corporate Governance Committee reviews with the Board the skills and
characteristics required of Board members. The committee will consider a candidates independence,
as well as the perceived needs of the Board and the candidates background, skills, business
experience and expected contributions. At a minimum, members of the Board must possess the highest
professional ethics, integrity and values, and be committed to representing the long-term interests
of our shareholders.
Page 12
They must also have an inquisitive and objective perspective, practical wisdom and mature judgment.
The committee may also take into account the benefits of diverse viewpoints, as well as the
benefits of constructive working relationships among directors.
The Nominating and Corporate Governance Committee also reviews and determines whether existing
members of the Board should stand for re-election, taking into consideration matters relating to
the number of terms served by individual directors and the changing needs of the Board. We do not
have a limit on the number of terms an individual may serve as a director on our Board.
The Nominating and Corporate Governance Committee utilizes a variety of methods for
identifying and evaluating nominees for director. The committee regularly assesses the appropriate
composition, size and independence of the Board, and whether any vacancies are expected due to
change in employment or otherwise. In the event that vacancies are anticipated, or otherwise arise,
the committee considers various potential candidates for director. Candidates are evaluated at
regular or special meetings of the Nominating and Corporate Governance Committee, and may be
considered at any point during the year. The committee will consider shareholder recommendations
for candidates for the Board that are properly submitted in accordance with Section 4.16 of our
by-laws in the same manner it considers nominees from other sources. In evaluating such
recommendations, the committee will use the qualifications standards described above and will seek
to achieve a balance of knowledge, experience and capability on the Board.
SHAREHOLDER COMMUNICATIONS WITH THE BOARD
Any shareholder who wishes to communicate directly with the Board may do so via mail or
facsimile, addressed as follows:
Net 1 UEPS Technologies, Inc.
Board of Directors
P O Box 2424
Parklands, 2121
Gauteng, South Africa
Fax: 27 11 880 7080
The corporate secretary shall transmit any communication to the Board, or individual
director(s), as applicable, as soon as practicable upon receipt. Absent safety or security
concerns, the corporate secretary shall relay all communications, without any other screening for
content.
CORPORATE GOVERNANCE GUIDELINES
The Board has adopted a set of corporate governance guidelines. We will continue to monitor
our corporate governance guidelines and adopt changes as necessary to comply with rules adopted by
the SEC and Nasdaq, and to conform to best industry practice. This will include comparing our
existing policies and practices to policies and practices suggested by various groups or
authorities active in corporate governance and the practices of other public companies. A copy of
our corporate governance guidelines is available on our website at
www.net1ueps.com under the
Financial Info Corporate Governance section.
CODE OF ETHICS
The Board has adopted a written code of ethics, as defined in the regulations of the SEC. We
require all directors, officers, employees, contractors, consultants and temporary staff, including
our Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer or controller
and other senior
Page 13
personnel performing similar functions, to adhere to this code in addressing the legal and ethical
issues encountered in conducting their work. Our code of ethics requires avoidance of conflicts of
interest, compliance with all laws and other legal requirements, conduct of business in an honest
and ethical manner, integrity and actions in our best interest. Directors, officers and employees
are required to report any conduct that they believe in good faith to be an actual or apparent
violation of the code. The Sarbanes-Oxley Act of 2002 requires companies to have procedures to
receive, retain and treat complaints received regarding accounting, internal accounting controls or
auditing matters and to allow for the confidential and anonymous submission by employees of
concerns regarding questionable accounting or auditing matters. We currently have such procedures
in place. A copy of our code of ethics is available upon request made either by mail to our
corporate secretary at Net 1 UEPS Technologies, Inc., P O Box 2424, Parklands 2121, Gauteng, South
Africa or by telephone to our Investor Relations Department at + 1 604 484-8750. A copy of our code
of ethics is also available free of charge on our website at
www.net1ueps.com under the Financial
Info Corporate Governance section. The information on our website is not, and shall not be
deemed to be, a part of this proxy statement or incorporated into any of our other filings made
with the SEC.
COMPENSATION OF DIRECTORS
Directors who are also executive officers do not receive separate compensation for their
services as directors. During fiscal 2008, certain directors who are not executive officers
received compensation as described below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or |
|
|
|
|
|
|
Paid in Cash |
|
Stock Awards |
|
|
Name |
|
(U.S.$) |
|
(U.S.$) |
|
Total |
Christopher
Seabrooke |
|
$ |
100,000 |
|
|
$ |
50,000 |
(1) |
|
$ |
150,000 |
|
Paul Edwards |
|
$ |
65,000 |
|
|
$ |
35,000 |
(2) |
|
$ |
100,000 |
|
|
|
|
(1) |
|
Represents 1,931 shares of restricted stock granted on February 6, 2008, one-third of
which will vest on each of February 6, 2009, 2010 and 2011. Vesting of such shares is conditioned
upon Mr. Seabrookes continuous service as a member of our Board through the applicable vesting
date. The value reflected is based on the closing price of our common stock on the date of grant. |
|
(2) |
|
Represents 1,351 shares of restricted stock granted on February 6, 2008, one-third of
which will vest on each of February 6, 2009, 2010 and 2011. Vesting of such shares is conditioned
upon Mr. Edwards continuous service as a member of our Board through the applicable vesting date.
The value reflected is based on the closing price of our common stock on the date of grant. |
During August 2007, our Board approved cash compensation for Messrs. Seabrooke and Edwards of
$100,000 and $65,000, respectively, for their services in respect of fiscal 2008. The Board made
this determination based on an analysis of the annual compensation of non-executive directors of
U.S. and UK-listed transaction processor companies with a range of market equity capitalizations
above, below and comparable to ours. The peer group comprised: Fiserv, Heartland Payments, Global
Payments, Inc., Wright Express Corp., Euronet Worldwide, Inc. and Dimension Data Plc. This peer
group is similar to the peer group used to determine our executive officers compensation.
However, during February 2008, our Board conducted a further review of the peer group
information described above and further considered the time and effort that was expected to be
required of Messrs. Seabrooke and Edwards in the future in performing services for us, and that
they are not paid separately for attending special meetings of the Board. Based on these
considerations, the Board determined that it
Page 14
would be appropriate to adjust the amount of the annual compensation paid to Messrs. Seabrooke and
Edwards for fiscal 2008 to $150,000 and $100,000, respectively, with the increase to be paid in the
form of an annual grant of restricted stock having a value of $50,000 in the case of Mr. Seabrooke
and $35,000 in the case of Mr. Edwards, with the number of shares to be derived by dividing such
values by the closing price of our common stock on the date of grant. The Board determined to make
the adjustment in February 2008 for the 2008 fiscal year and that for fiscal 2009 and afterwards,
the restricted stock component of Messrs. Seabrookes and Edwards compensation would be awarded in
August to coincide with the timing of other stock-based awards under the Stock Incentive Plan.
Messrs. Ball and Pein have served as directors pursuant to an agreement between us and SAPEF.
We did not pay Messrs. Ball or Pein any compensation for their services as directors during fiscal
2008.
During fiscal 2008, Mr. Wendelstadt served as a director pursuant to an agreement between us
and investment entities affiliated with GA. We did not pay Mr. Wendelstadt any compensation for his
services as a director. Under this agreement, we are required to reimburse the travel and
accommodation expenses incurred in connection with his attendance at our Board and committee
meetings. Mr. Wendelstadt did not claim any reimbursements in the fiscal 2008 year.
EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
Overview
The goal of our executive compensation program is the same as our goal for operating the
companyto create long-term value for our shareholders. To achieve this goal, we seek to reward our
named executive officers for sustained financial and operating performance and leadership
excellence, to align their interests with those of our shareholders and to encourage them to remain
with us for long and rewarding careers. This section of the proxy statement explains how our
compensation program is designed and operates in practice with respect to the four individuals who
comprised our named executive officers during our 2008 fiscal yearour Chief Executive Officer, our
Chief Financial Officer, our Senior Vice President-Marketing and Sales and our Senior Vice
President-Information Technology. Our named executive officers have the broadest job
responsibilities and are the only individuals who have policy-making authority.
Each element of our executive compensation program is designed to fulfill one or more of our
performance, alignment and retention objectives. These elements consist of salary, bonus and both
equity and non-equity incentive compensation. In determining the type and amount of compensation
for each executive officer, we focus on both current pay and the opportunity for future
compensation and seek to combine compensation elements so as to optimize his or her contribution to
us. We consider the mix of our compensation components from year to year based on our overall
performance, an executives individual contributions and compensation practices of other U.S. and
UK based public companies including companies in our peer group described below. We do not have
an exact formula for allocating between cash and non-cash compensation. We do, nonetheless, provide
for a balanced mix of compensation components that are designed to encourage and reward behavior
that promotes shareholder value in both the short and long term.
Compensation Objectives
Performance. Each of our named executive officers who served as such during fiscal 2008 has
had a long and distinguished career with us. In particular, our Chief Executive Officer founded the
Company
Page 15
and developed the technology on which our products are based. We reward excellent performance by
our named executive officers and motivate them to continue to produce superior, long-term results
through a combination of cash bonuses, incentive payments that depend on achievement of pre-defined
levels of financial and operating goals and equity awards in the form of stock options or
restricted stock that derive their value from increases in our share price and/or satisfaction of
other financial performance goals. Base salary, bonus and non-equity incentive compensation are
designed to reward annual achievements and be commensurate with each executive officers scope of
responsibility, demonstrated ingenuity, dedication and leadership and management effectiveness.
Equity incentive compensation focuses on achievement of longer term results.
Alignment. We seek to align the interests of our named executive officers with our
shareholders by evaluating them on the basis of financial and non-financial measurements that we
believe correlate to long-term shareholder value. Financial measures include growth in revenues,
EBITDA and earnings per share (on both a South African rand, or ZAR and U.S. dollar basis), while
non-financial measures include international expansion of our UEPS technology and the achievement
of strategic operational goals. The elements of our compensation package that we believe align
these interests most closely are stock option awards which increase in value as our stock price
increases and restricted stock awards which vest over time and upon the satisfaction of our
performance goals.
Retention. Our executive officers and the Remuneration Committee recognize that the talent
pool in South Africa is more limited than in other more developed countries. Even more
significantly, the long tenure of our named executive officers has made them especially
knowledgeable about our business and industry and thus particularly valuable to the Company. We
wish to avoid losing these long-tenured officers and their invaluable knowledge, particularly given
how important they are to the future performance of the Company. Therefore, retention is a key
objective of our executive compensation program insofar as same relates to our South African-based
named executive officers. We attempt to retain our key employees, including our named executive
officers, by seeking to provide a competitive pay package and using continued service as a
condition to receipt of full compensation. The extended vesting terms of stock options and
restricted stock awards have the effect of tying this element of compensation to continued service
with us.
Implementing our Objectives
Process for Determining Compensation. A substantial amount of the Remuneration Committees
responsibilities and efforts relate to the determination of compensation for our named executive
officers. The Remuneration Committee obtains compensation data compiled from executive compensation
surveys which include data gathered from annual reports and proxy statements of companies that it
selects as a peer group for executive compensation analysis purposes. The Remuneration
Committees goal is that the total cash compensation for our named executive officers be at the
75th percentile and the overall equity compensation for named executive officers should be within
the range of the 50th to 75th percentiles when our financial performance equals the average of our
peer group companies. Because of the high proportion of cash compensation that is at risk, the
Remuneration Committee reserves the right to adjust total cash compensation to be higher or lower,
when our financial performance exceeds that of our peer group companies or is lower than that of
our peer group companies, as the case may be. Our peer group consists of payment processing
companies generally considered comparable to us as well other companies within the information
technology sector and those engaged in emerging markets. The Remuneration Committees intent
generally is to choose peer group members that have one or more attributes significantly similar to
us, such as that of being a payment systems provider. Our peer group, which includes both U.S. and
UK listed companies, consists of the following companies: Fiserve Inc, Global Payments, Inc.,
Wright Express Corporation, Euronet Worldwide Inc, Hartland Payment Systems Inc, and Dimension Data
Holdings Plc.
Page 16
The Remuneration Committees process for determining compensation includes an analysis, for
each executive officer, of all elements of compensation. The Remuneration Committee compares these
compensation components separately and in total to compensation at the peer group companies. The
Remuneration Committee sets the compensation of our Chief Financial Officer based on the total
compensation package of our Chief Executive Officer. Since the role played by our Chief Financial
Officer is significantly broader than that of a typical Chief Financial Officer, the Remuneration
Committees goal is to set this package at approximately 45%-65% of our Chief Executive Officers
total compensation package. Each of our other named executive officers compensation is then set at
approximately 50% of the compensation of our Chief Financial Officer. Because the Remuneration
Committee considers international comparables in its compensation analysis for both our Chief
Executive Officer and Chief Financial Officer, their total compensation packages are denominated in
U.S. dollars. Because our other South African-based named executive officers compensation packages
are derived from the amount of compensation we pay to our Chief Financial Officer, their
compensation packages are also denominated in U.S. dollars. Our executive officers may elect to be
paid in a currency other than USD, in which case the USD amount is converted into ZAR at the
exchange rate in effect at the time of payment. In the first quarter of each year, the Remuneration
Committee establishes base salaries and sets the short-term cash incentive plan remuneration
targets and payment criteria. Following the end of each fiscal year, the Remuneration Committee
determines the annual incentive cash payments and bonuses, if any, to be made to each named
executive officer based on their and our performance during the fiscal year.
Before the Remuneration Committee makes decisions on compensation for the year, it discusses
with our Chief Executive Officer each executive officers performance during the year, his or her
accomplishments and specific areas of progress. Our Chief Executive Officer bases his evaluation on
his knowledge of each executive officers performance (with due regard to the operational
environment) and targets that have been set for a particular performance period. The named
executive officers are then evaluated based on their individual performance during the fiscal year.
The Chief Executive Officer makes a recommendation to the Remuneration Committee on each executive
officers compensation, except for his own and the Chief Financial Officers compensation. Named
executive officers do not propose or seek approval for their own compensation. Our Chief Executive
Officers and Chief Financial Officers annual performance review is developed by the Remuneration
Committee as a whole. For our Chief Executive Officers and Chief Financial Officers reviews,
formal feedback is received from the non-employee directors.
The non-employee directors perform reviews for the employee directors, which are completed and
presented to the Chief Executive Officer before the Remuneration Committee determines base salary,
bonus and incentive award targets and equity awards. In determining base salary, target cash
incentives and bonus amounts and equity awards, the Remuneration Committee reviews group
performance as well as individual performance information and our peer group executive compensation
data.
The Remuneration Committee also consults with our Chief Executive Officer and Chief Financial
Officer regarding non-executive officer employee compensation and is responsible for approving all
awards under our Stock Incentive Plan.
Equity Grant Practices. We believe that long-term performance is achieved through a culture
that encourages such performance by our named executive officers through the use of stock and
stock-based awards. Accordingly, awards of stock options and restricted stock are a fundamental
element in our executive compensation program because they emphasize long-term performance, as
measured by creation of shareholder value, and foster a commonality of interest between
shareholders and employees. We have granted equity awards primarily through our Stock Incentive
Plan, which was adopted by our
Page 17
Board of Directors and approved by our shareholders, to permit the grant of stock options and other
stock-based awards to our employees, directors and consultants. Options granted under the plan vest
ratably over a period of five years after grant unless otherwise provided in a particular award
agreement and have ten-year terms from the date of grant. In determining the size of an equity
award to an executive officer, the methodology adopted by the Remuneration Committee entails the
consideration of the executives then current cash total compensation package (which includes
salary, potential bonus and cash incentive plan compensation), any previously received equity
awards, the value of the grant at the time of award and the number of shares available for grants
pursuant to our Stock Incentive Plan.
We adopted Financial Accounting Standards Board Statement No. 123 (revised 2004), Share-Based
Payments (FAS 123R) at the beginning of fiscal year 2006 and, therefore, record stock-based
compensation charges over the vesting term of the equity award. When awarding equity compensation,
management and the Remuneration Committee seek to weigh the cost of these grants with their
potential benefits as a compensation tool. We believe that combining grants of stock options and
restricted stock effectively balances our objective of focusing our employees, including our named
executive officers, on delivering long-term value to our shareholders, with our objective of
providing value to our employees with the equity awards. Stock options have value only to the
extent that our stock price on the date of exercise exceeds the stock price on the date of grant,
and thus are an effective compensation tool only if the stock price appreciates during the vesting
term. In this sense, stock options are a motivational tool. Awards of restricted stock that include
financial performance-based vesting over a stated period of time not only serve to encourage
retention and motivate our employees for superior performance but also mitigate the effects of
share price volatility and changes in the currency exchange rates. Such changes in the currency
exchange rates affect our reported results of operations because our functional currency is the ZAR
and we report our results in U.S. dollars.
No Employment Agreements. Our named executive officers who served as such for fiscal 2008 are
all employed on an at will basis, without employment agreements, severance payment arrangements
(except as required by local labor laws), or payment arrangements that would be triggered by a
change in control. The absence of such arrangements enables us to terminate the employment of our
named executive officers with discretion as to the terms of any severance arrangement. This is
consistent with our performance-based employment and compensation philosophy. We do have restraint
of trade agreements with each of our named executive officers. The terms of these agreements
provide that upon the termination of the executives employment, the executive is restricted, for a
period of 24 months, from soliciting business from certain customers, working for or holding
interests in our competitors or participating in a competitive activity within the territories
where we do business.
Considerations Regarding Tax Deductibility of Compensation. Section 162(m) of the U.S. tax
code places a limit of $1 million on the amount of compensation that we may deduct in any one year
with respect to each of our named executive officers (other than our Chief Financial Officer, to
whom these limits do not currently apply). Certain qualified performance-based compensation is not
subject to this deduction limit. Our stock option awards under the Stock Incentive Plan have been
structured with the intention that the compensation the executives will realize when the stock
options are exercised will be qualified performance-based compensation not subject to the
limitations imposed by Section 162(m). However, to maintain flexibility in compensating our named
executive officers in a manner designed to promote our various corporate goals, it is not a policy
of the Remuneration Committee that all executive compensation must be tax-deductible. For example,
the bonuses and non-equity incentive compensation payments made to our named executive officers are
not qualified performance-based compensation and may be subject to the tax deduction limitations
imposed by Section 162(m). Similarly, the restricted stock granted to our named executive officers,
the vesting of which is conditioned upon satisfaction of our performance goals, may be subject to
the tax deductibility limitations imposed by Section 162(m) because the Remuneration Committee
retained flexibility to adjust the performance goals to reflect extraordinary
Page 18
events. The Remuneration Committee believes that the importance of retaining this flexibility
outweighs the benefits of tax deductibility.
Compensation Consultants. Neither we nor the Remuneration Committee have any contractual
arrangement with any compensation consultant or used the services of any compensation consultant
who has a role in determining or recommending the amount or form of executive officer compensation.
Elements of 2008 Compensation
There are four elements that comprised our compensation program in fiscal 2008: (i) base
salary; (ii) cash incentive awards for our Chief Executive Officer and Chief Financial Officer;
(iii) bonus for our Senior Vice-President Marketing and Sales and our Senior Vice-President
Information Technology and (iv) equity incentive awards for each of our named executive officers.
In addition, we cover all costs for security guards for our Chief Executive Officer. We did not
provide any other type of compensation, retirement, healthcare, or welfare benefits to any of our
named executive officers.
Base Salary. Salaries for fiscal 2008 were determined in the first quarter of the 2008 fiscal
year after a review of our peer group companies described above.
Cash Incentive Awards. During the first quarter of fiscal 2008, the Remuneration Committee
established a cash incentive plan for the Chief Executive Officer and the Chief Financial Officer
pursuant to which these officers became eligible to receive a cash incentive payment of 100% and
75%, respectively, of their respective annual salaries upon the achievement of certain performance
targets with respect to the 2008 fiscal year. In determining the cash incentive awards for the
Chief Executive Officer and Chief Financial Officer, the Remuneration Committee set certain
separate quantitative and qualitative criteria. With respect to the Chief Executive Officer, 60%
of the potential cash incentive award was based on pure earnings per shares, or EPS growth of 25%
(after reversing the stock-based compensation charge and amortization of intangible assets) with a
weighting between U.S. dollars and ZAR, respectively, of 60%/40%. The Remuneration Committee
determined that 40% of the potential cash incentive award to be granted to the Chief Executive
Officer would be based on the achievement of certain qualitative goals including: (i) achievement
of operational milestones, specifically with respect to international business expansion; (ii) the
continued strengthening of the executive management team and (iii) increased focus on strategic as
opposed to operational matters.
Likewise, with respect to the Chief Financial Officer, 70% of the potential cash incentive
award was based on pure EPS growth of 25% (after reversing the stock-based compensation charge and
amortization of intangible assets) with a weighting between U.S. dollars and ZAR, respectively, of
60%/40%. The Remuneration Committee also determined that 30% of the potential cash incentive award
to be granted to the Chief Financial Officer would be based on the achievement of certain
qualitative goals including: (i) the continued strengthening of the executive management team, (ii)
the successful performance of such tasks as the Chief Executive Officer may reasonably require of
the Chief Financial Officer, and (iii) increased focus by the Chief Financial Officer on corporate
development as opposed to regulatory issues.
Following the end of fiscal 2008, the Remuneration Committee determined that the quantitative
requirements had been satisfied and that the qualitative requirements had been sufficiently
achieved by each of the Chief Executive Officer and the Chief Financial Officer to justify the full
cash incentive awards, which were subsequently paid in September 2008. Aside from our achieving the
required EPS growth, which exceeded 25% both on a U.S. dollars and ZAR basis, the Remuneration
Committee also considered qualitative achievements to have been adequately achieved in the 2008
fiscal year in arriving at its decision to grant the full cash incentive awards to the Chief
Executive Officer and the Chief Financial Officer. Specifically, the committee considered the
efforts to expand the geographical presence
Page 19
of the business beyond South Africa. It was acknowledged that significant progress had been made in
both Ghana and Iraq as well as with the acquisition of BGS Smart Card Systems AG. The Remuneration
Committee discussed and was satisfied that considerable progress had also been achieved in the
continual strengthening and deepening of the management team, allowing Dr. Belamant and Mr. Kotze
to spend more time and effort on strategic positioning of the business and corporate development.
In addition, the acquisition of EasyPay had been well integrated into our operations.
Bonus. Bonuses may be awarded for accomplishments during the previous fiscal year and are
designed to be commensurate with the executives scope of responsibilities, demonstrated leadership
abilities, management experience and effectiveness. Likewise, with respect to the Chief Executive
Officer and the Chief Financial Officer, bonuses may be paid for performance based on factors
external to the ones considered in determining the payment of the cash incentive awards described
above. Bonuses are determined by the Remuneration Committee with advice from the management
directors, based upon the Remuneration Committees assessment of the individuals contributions
during the year, compared to, but not limited to, a list of individualized goals previously
approved by the executive officers and the Remuneration Committee. The goal of this element of
compensation focuses on motivating and challenging the executive to achieve superior, longer term,
sustained results. The Remuneration Committee did not grant any bonus awards in the 2008 fiscal
year to our Chief Executive Officer and Chief Financial Officer as it was of the opinion that the
cash incentive awards adequately compensated these executives. Our Vice-President Sales and
Marketing and Vice-President Information Technology received bonuses as a result of their
contributions to our advancements in international growth, including growth in Iraq and Ghana and
development of new and innovative products.
Equity Incentive Awards. In August 2007, the Remuneration Committee approved grants of an
aggregate of 145,000 shares of restricted stock to our named executive officers as set out in more
detail in the Grants of Plan-Based Awards table below. The primary purpose of these grants was to
encourage retention and reward positive financial performance of the Company. One-third of the
award shares will vest on each of September 1, 2009, 2010 and 2011. Vesting of the award shares is
conditional upon each recipients continuous service through the applicable vesting date and the
Company achieving the financial performance target set for that vesting date. Specifically, the
financial performance targets were set based on a 25% increase (in the case of Dr. Belamant and Mr.
Kotze) and a 20% increase (in the case of Ms. Stewart and Mr. Soma ), compounded annually, in
fundamental earnings per share (diluted) (expressed in ZAR) above the fundamental EPS for the
fiscal year ended June 30, 2007. For this purpose, fundamental EPS are calculated by adjusting
accounting principles generally accepted in the United States, EPS (diluted) (as reflected in the
Companys audited consolidated financial statements) to exclude the effects related to the
amortization of intangible assets, stock-based compensation charges, one-time, large, unusual
expenses as determined in the discretion of the Remuneration Committee, and assuming a constant tax
rate of 30%. If the fundamental EPS for the specified fiscal year do not equal or exceed the
fundamental EPS target for such year, no award shares will vest or become nonforfeitable on the
corresponding vesting date. Any award shares that do not vest and become nonforfeitable because the
fundamental EPS target is not met for the specified fiscal year remain outstanding and are
available to vest and become nonforfeitable as of a subsequent vesting date if the fundamental EPS
target for a subsequent fiscal year is met; provided that the recipients service continues through
such subsequent vesting date. Any outstanding award shares that have not vested and become
nonforfeitable as of September 1, 2011, will be forfeited by the recipient on September 1, 2011 and
transferred to the Company for no consideration.
The fundamental EPS targets will be proportionately adjusted by the Remuneration Committee for
any stock split, reverse stock split, stock dividend, share combination, recapitalization or
similar event effected subsequent to the date of grant. The Remuneration Committee, in its sole
discretion, may adjust the targets as it considers in good faith to be appropriate to reflect
extraordinary items including,
Page 20
without limitation, the charges or costs associated with restructuring of the Company, discontinued
operations, other unusual or nonrecurring items, and the cumulative effects of accounting changes.
Security Guards for our Chief Executive Officer. We provide on-site residential security
services for Dr. Belamant consisting of two armed guards. These services are provided based on bona
fide business related security concerns and are an integral part of the Companys overall risk
management program. The Board believes that provision of these security services is a necessary and
appropriate business expense because Dr. Belamants personal safety and security are of the utmost
importance to the Company and its shareholders. These security services may be viewed as conveying
a personal benefit to Dr. Belamant and as a result, must be reported in the Summary Compensation
Table below.
REMUNERATION COMMITTEE REPORT
For the Year Ended June 30, 2008
The Remuneration Committee, which comprises all the independent directors, has reviewed and
discussed the Compensation Discussion and Analysis section of this proxy statement with the Chief
Executive Officer, Dr. Serge C.P. Belamant, and the Chief Financial Officer, Herman G. Kotzé. Based
on this review and discussion, the Remuneration Committee recommended to our Board of Directors
that the Compensation Discussion and Analysis section be included in our Annual Report on Form
10-K and this proxy statement.
Remuneration Committee
Alasdair J.K. Pein
Christopher Stefan Seabrooke
Antony Charles Ball
Paul Edwards
Tom C. Tinsley
Page 21
Executive Compensation Tables
The following narrative, tables and footnotes describe the total compensation earned during
fiscal years 2008 and 2007, as applicable, by our named executive officers. The total compensation
presented below in the Summary Compensation Table does not reflect the actual compensation received
by our named executive officers or the target compensation of our named executive officers in
fiscal 2008. The actual value realized by our named executive officers in fiscal 2008 from
long-term equity incentives (options and restricted stock) is presented in the Options Exercised
and Stock Vested Table on page 25 of this proxy statement. Target annual incentive awards for
fiscal 2008 are presented in the Grants of Plan-Based Awards table on page 23 of this proxy
statement. The amounts reflected in the Summary Compensation Table for stock awards and option
awards are the non-cash expense recognized by us for financial statement reporting purposes with
respect to fiscal 2008 and 2007 for all such awards, including those granted in prior fiscal years,
in accordance with FAS 123R.
SUMMARY COMPENSATION TABLE (1)
The following table sets forth the compensation earned by our Chief Executive Officer, our
Chief Financial Officer and our other named executive officers for services rendered during fiscal
years 2008 and 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive |
|
All |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
Option |
|
Compens |
|
Compens |
|
|
|
|
|
|
|
|
Salary |
|
Bonus |
|
Awards |
|
Awards |
|
-ation |
|
-ation |
|
|
Name and |
|
|
|
|
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
Total |
Principal Position |
|
Year |
|
(2) |
|
(3) |
|
(4) |
|
(5) |
|
(3) |
|
(6) |
|
($000) |
Dr. Serge Belamant, Chief Executive
Officer, |
|
|
2008 |
|
|
|
850 |
|
|
|
|
|
|
|
205 |
|
|
|
88 |
|
|
|
850 |
|
|
|
41 |
|
|
|
2,034 |
|
Chairman of the Board and Director |
|
|
2007 |
|
|
|
725 |
|
|
|
|
|
|
|
|
|
|
|
79 |
|
|
|
725 |
|
|
|
39 |
|
|
|
1,568 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herman Kotzé, Chief Financial Officer, |
|
|
2008 |
|
|
|
425 |
|
|
|
|
|
|
|
205 |
|
|
|
38 |
|
|
|
319 |
|
|
|
|
|
|
|
987 |
|
Treasurer, Secretary and Director |
|
|
2007 |
|
|
|
350 |
|
|
|
|
|
|
|
|
|
|
|
35 |
|
|
|
263 |
|
|
|
|
|
|
|
648 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brenda Stewart, Vice-President |
|
|
2008 |
|
|
|
312 |
|
|
|
78 |
|
|
|
181 |
|
|
|
27 |
|
|
|
|
|
|
|
|
|
|
|
598 |
|
Sales and Marketing |
|
|
2007 |
|
|
|
260 |
|
|
|
65 |
|
|
|
|
|
|
|
25 |
|
|
|
|
|
|
|
|
|
|
|
350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitin Soma, Vice-President |
|
|
2008 |
|
|
|
288 |
|
|
|
72 |
|
|
|
156 |
|
|
|
22 |
|
|
|
|
|
|
|
|
|
|
|
538 |
|
Information Technology |
|
|
2007 |
|
|
|
230 |
|
|
|
58 |
|
|
|
|
|
|
|
20 |
|
|
|
|
|
|
|
|
|
|
|
308 |
|
|
|
|
(1) |
|
Includes only those columns relating to compensation awarded to, earned by, or paid to the
named executive officers in either fiscal 2008 or 2007. All other columns have been omitted. |
|
(2) |
|
The applicable amount for each named executive officer is denominated in USD and paid in ZAR at
the exchange rate in effect at the time of payment. |
|
(3) |
|
Bonus and non-equity incentive plan compensation represent amounts earned for the fiscal
years ended June 30, 2008 and 2007 that were paid in September 2008 and 2007, respectively.
The amounts for each
executive officer are denominated in USD. |
Page 22
|
|
|
(4) |
|
Represents grants of shares of restricted stock awarded to our named executive officers in
August 2007, one-third of which will vest on each of September 1, 2009, 2010 and 2011. Vesting of
the award shares is conditioned upon each recipients continuous service through the applicable
vesting date and the Company achieving the financial performance target set for that vesting date.
See note 13 to the consolidated financial statements included in our Annual Report on Form 10-K for
the year ended June 30, 2008 for the relevant assumptions used in calculating grant date fair value
under FAS 123R. For further information about these awards, see Compensation Discussion and
Analysis Elements of 2008 Compensation Equity Incentive Awards above. |
|
(5) |
|
Represents actual stock-based plan compensation charge related to stock options granted under
the Stock Incentive Plan to our named executive officers. The amounts are valued based on the grant
date fair value of the award determined under FAS123R. See note 13 to the consolidated financial
statements included in our
Annual Report on Form 10-K for the year ended June 30, 2008 for the relevant assumptions used
in calculating grant date fair value under FAS 123R. For further information about these
awards, see the Grants of Plan-Based Awards table below. |
|
(6) |
|
Represents costs for security guards for Dr. Belamant, which is paid in ZAR. |
GRANTS OF PLAN-BASED AWARDS
The following table provides information concerning awards under our Stock Incentive Plan and
non-equity incentive awards granted during fiscal 2008 to each of our named executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Future |
|
Estimated Future Payouts |
|
Grant Date Fair Value |
|
|
|
|
|
|
Payouts Under Non- |
|
Under Equity Incentive |
|
of Stock and Option |
|
|
|
|
|
|
Equity Incentive |
|
Plan Awards |
|
Awards |
|
|
|
|
|
|
Plan Awards (1) |
|
(2) |
|
($000) (3) |
|
|
|
|
|
|
Target |
|
Target |
|
|
|
|
Name |
|
Grant date |
|
($000) |
|
(number of shares) |
|
|
|
|
Dr. Serge Belamant |
|
|
8/01/07 |
|
|
|
850 |
|
|
|
40,000 |
|
|
|
910 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herman Kotzé |
|
|
8/01/07 |
|
|
|
319 |
|
|
|
40,000 |
|
|
|
910 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brenda Stewart |
|
|
8/01/07 |
|
|
|
n/a |
|
|
|
35,000 |
|
|
|
804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitin Soma |
|
|
8/01/07 |
|
|
|
n/a |
|
|
|
30,000 |
|
|
|
689 |
|
|
|
|
(1) |
|
In the first quarter of fiscal 2008, the Remuneration Committee approved a cash incentive plan
providing for a payment of 100% of Dr. Belamants $850,000 annual base salary and 75% of Mr.
Kotzes $425,000 annual base salary, if certain quantitative and qualitative requirements were met
for our fiscal 2008 year. The Remuneration Committee determined that Dr. Belamant and Mr. Kotze
satisfied the quantitative requirements and that the qualitative requirements had been sufficiently
achieved to justify the full cash incentive award which was paid in September 2008. See the
discussion under Compensation Discussion and Analysis Elements of 2008 Compensation Cash
Incentive Awards for the performance targets established by the Remuneration Committee and the
reasons underlying the Remuneration Committees determination regarding the qualitative targets. |
|
(2) |
|
In August 2007, the Remuneration Committee approved grants of restricted stock to our named
executive officers. See the discussion under Compensation Discussion and Analysis Elements of
2008 Compensation Equity Incentive Awards for the performance targets, vesting schedules and
other terms applicable to these awards. |
|
(3) |
|
Grant Date Fair Value was derived by multiplying the closing price of our common stock on
August 1, 2007, the grant date, by the number of shares of restricted stock granted. |
Page 23
OUTSTANDING EQUITY AWARDS AT 2008 FISCAL YEAR-END
The following table shows all outstanding equity awards held by our named executive officers
at the end of fiscal 2008. The market value of unvested shares reflected in this table is
calculated by multiplying the number of unvested shares by the closing price of $24.30 of our
common stock on June 30, 2008, the last trading day of the fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards |
|
|
Stock Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive |
|
|
Incentive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan |
|
|
Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards: |
|
|
Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number |
|
|
Market |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of |
|
|
or Payout |
|
|
|
|
|
|
|
Number |
|
|
|
|
|
|
|
|
|
|
Unearned |
|
|
Value of |
|
|
|
|
|
|
|
of |
|
|
|
|
|
|
|
|
|
|
Shares, |
|
|
Unearned |
|
|
|
|
|
|
|
Securities |
|
|
|
|
|
|
|
|
|
|
Units or |
|
|
Shares, |
|
|
|
Number of |
|
|
Under- |
|
|
|
|
|
|
|
|
|
|
Other |
|
|
Units or |
|
|
|
Securities |
|
|
lying |
|
|
|
|
|
|
|
|
|
|
Rights |
|
|
Other |
|
|
|
Underlying |
|
|
Unexer- |
|
|
|
|
|
|
|
|
|
|
That |
|
|
Rights |
|
|
|
Unexer- |
|
|
cised |
|
|
Option |
|
|
|
|
|
|
Have Not |
|
|
That |
|
|
|
cised |
|
|
Options |
|
|
Exercise |
|
|
Option |
|
|
Vested |
|
|
Have Not |
|
|
|
Options (#) |
|
|
(#) |
|
|
Price |
|
|
Expiration |
|
|
(number |
|
|
Vested |
|
Name |
|
Exercisable |
|
|
Unexercisable |
|
|
($) |
|
|
Date |
|
|
of shares) |
|
|
($) |
|
Dr. Serge
Belamant |
|
|
16,670 |
|
|
|
|
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
40,000 |
(2) |
|
|
972 |
(3) |
|
|
|
32,000 |
|
|
|
48,000 |
(1) |
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herman Kotzé |
|
|
16,670 |
|
|
|
|
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
40,000 |
(2) |
|
|
972 |
(3) |
|
|
|
14,000 |
|
|
|
21,000 |
(1) |
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brenda Stewart |
|
|
33,336 |
|
|
|
|
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
35,000 |
(2) |
|
|
851 |
(3) |
|
|
|
10,000 |
|
|
|
15,000 |
(1) |
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitin Soma |
|
|
8,000 |
|
|
|
12,000 |
(1) |
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
30,000 |
(2) |
|
|
729 |
(3) |
|
|
|
(1) |
|
One-third of these options vest on each of May 8, 2009, 2010 and 2011, respectively. |
|
(2) |
|
Represents restricted stock of which one-third of the award shares will vest on each of
September 1, 2009, 2010 and 2011. Vesting of the award shares is conditioned upon each recipients
continuous service through the applicable vesting date and our achieving the financial performance
target set for that vesting date. |
|
(3) |
|
Assumes that all performance targets will be met in each year and all shares of restricted
stock will vest on each of September 1, 2009, 2010 and 2011. |
Page 24
OPTIONS EXERCISED AND STOCK VESTED
The following table shows all stock options exercised and value realized upon exercise by the
named executive officers during fiscal 2008.
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
|
|
Number of Shares |
|
|
Value Realized on |
|
|
|
Acquired on |
|
|
Exercise |
|
Name |
|
Exercise (#) |
|
|
($000)(1) |
|
Dr. Serge Belamant |
|
|
16,666 |
|
|
|
346 |
|
|
Herman Kotzé |
|
|
16,666 |
|
|
|
346 |
|
|
Brenda Stewart |
|
|
|
|
|
|
|
|
|
Nitin Soma |
|
|
33,336 |
|
|
|
712 |
|
|
|
|
(1) |
|
The value realized in connection with each option exercise is calculated as the difference
between the per share exercise price of the option and the closing price of our common stock on the
date of exercise, multiplied by the number of shares of common stock for which such option was
exercised on that date. |
POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE-IN-CONTROL
As described above under Compensation Discussion and Analysis, we do not have employment,
severance or change of control agreements with named executive officers. Accordingly, there would
be no compensation, other than that prescribed by local labor laws in the case of unfair dismissal
or retrenchment, that would become payable under the existing plans and arrangements if the
employment of any of our named executive officers had terminated on June 30, 2008.
We do not have any on-going obligation to provide post-termination benefits to our named executive
officers after termination of employment.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Review, Approval or Ratification of Related Person Transactions
We review all relationships and transactions in which we and our directors and named executive
officers or their immediate family members are participants to determine whether such persons have
a direct or indirect material interest. Our Chief Executive Officer and Chief Financial Officer are
primarily responsible for the development and implementation of processes and controls to obtain
information from the directors and named executive officers with respect to related person
transactions and for then determining, based on the facts and circumstances, whether we or a
related person has a direct or indirect material interest in the transaction. As required under SEC
rules, transactions that are determined to be directly or indirectly material to us or a related
person are disclosed in our proxy statement. In addition, our Audit Committee reviews and approves
or ratifies any related person transaction that is required to be disclosed. In the course of its
review and approval or ratification of a disclosable related party transaction, our Audit Committee
considers:
|
|
|
the nature of the related persons interest in the transaction; |
|
|
|
|
the material terms of the transaction, including, without limitation, the amount and
type of transaction; |
Page 25
|
|
|
the importance of the transaction to the related person; |
|
|
|
|
the importance of the transaction to us; |
|
|
|
|
whether the transaction would impair the judgment of a director or executive officer to
act in our best interest; and |
|
|
|
|
any other matters the committee deems appropriate. |
Any member of the Audit Committee who is a related person with respect to a transaction under
review may not participate in the deliberations or vote respecting approval or ratification of the
transaction, provided, however, that such director may be counted in determining the presence of a
quorum at a meeting of the committee that considers the transaction.
Related Party Transactions
Pursuant to the common stock purchase agreement, dated January 30, 2004, between us and SAPEF,
SAPEF is entitled to designate three nominees to our Board. SAPEF has informally agreed to reduce
the number of its designated nominees from three to two due to the recent reduction in the number
of our shares that SAPEF holds. Mr. Ball and Mr. Pein currently serve on our Board as SAPEFs
designees.
Pursuant to the stock purchase agreement, dated July 18, 2005, among the investment entities
affiliated with GA, us and certain other parties, GA is entitled to designate one nominee to our
Board. This designee was Mr. Wendelstadt during the 2008 fiscal year and is currently Mr. Tinsley,
who replaced Mr. Wendelstadt on September 1, 2008. In addition, pursuant to the stock purchase
agreement, we granted rights, under certain circumstances and subject to certain limitations, with
respect to the registration of our shares held by investment entities affiliated with GA.
AUDIT AND NON-AUDIT FEES
The following table shows the fees that we paid or accrued for the audit and other services
provided by Deloitte for the fiscal years ended June 30, 2008 and 2007.
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
2007 |
|
|
|
$ 000 |
|
|
$ 000 |
|
Audit Fees |
|
|
1,329 |
|
|
|
1,289 |
|
Audit-Related Fees |
|
|
|
|
|
|
|
|
Tax Fees |
|
|
|
|
|
|
|
|
All Other Fees |
|
|
|
|
|
|
|
|
Audit Fees This category includes the audit of our annual consolidated financial
statements, review of financial statements included in our quarterly reports on Form 10-Q, the
required audit of managements assessment of the effectiveness of our internal control over
financial reporting and the auditors independent audit of internal control over financial
reporting, and the services that an independent auditor would customarily provide in connection
with subsidiary audits, statutory requirements, regulatory filings, and similar engagements for the
fiscal year, such as comfort letters, attest services, consents, and assistance with review of
documents filed with the SEC. This category also includes advice on audit and accounting matters
that arose during, or as a result of, the audit or the review of interim financial statements.
Page 26
Audit-Related Fees This category consists of assurance and related services by the
independent registered public accounting firm that are reasonably related to the performance of the
audit or review of our financial statements and are not reported above under Audit Fees. There
were no such fees paid in the fiscal years ended June 30, 2008 or 2007.
Tax Fees This category consists of professional services rendered by Deloitte for tax
compliance and tax advice. The services for the fees disclosed under this category include tax
return review and technical tax advice. There were no such fees paid in the fiscal years ended June
30, 2008 or 2007.
All Other Fees There were no such fees paid in the fiscal years ended June 30, 2008 or
2007.
Pre-Approval of Non-Audit Services
Pursuant to our Audit Committee charter, our Audit Committee reviews and pre-approves both
audit and non-audit services to be provided by our independent auditors. The authority to grant
pre-approvals of non-audit services may be delegated to one or more designated members of the Audit
Committee whose decisions will be presented to the full Audit Committee at its next regularly
scheduled meeting. During fiscal years 2008 and 2007, all of the audit, audit-related, tax and
other services provided by Deloitte with respect to fiscal years 2008 and 2007 were pre-approved by
the Board and the Audit Committee.
AUDIT COMMITTEE REPORT
The Audit Committee of the Board consists of three independent directors, as required by
Nasdaq listing standards. The Audit Committee operates under a written charter adopted by the Board
and available on our website at www.net1ueps.com. The Audit Committee is responsible for overseeing
our financial reporting process on behalf of the Board. The members of the Audit Committee are
Messrs. Seabrooke, Pein and Edwards. The committee selects, subject to shareholder ratification,
our independent registered public accounting firm.
Management is responsible for our financial statements and the financial reporting process,
including internal controls. The independent registered public accounting firm is responsible for
performing an independent audit of our consolidated financial statements in accordance with
auditing standards generally accepted in the United States and of our internal control over
financial reporting and for issuing a report thereon. The committees responsibility is to monitor
and oversee these processes.
In this context, the Audit Committee has met and held discussions with management and
Deloitte. Our Chief Executive Officer and Chief Financial Officer represented to the Audit
Committee that the consolidated financial statements were prepared in accordance with accounting
principles generally accepted in the United States, and the committee reviewed and discussed the
consolidated financial statements with our Chief Executive Officer and Chief Financial Officer and
Deloitte. The Audit Committee discussed with Deloitte the matters required to be discussed by the
statement on Auditing Standards No. 61, as amended (AICPA, Professional Standards, Vol. 1. AU
§380), as may be modified or supplemented. These matters included a discussion of Deloittes
judgments about the quality (not just the acceptability) of our accounting principles as applied to
our financial reporting.
Deloitte also provided the Audit Committee with the written disclosures and letter required by
Independence Standards Board Standard No. 1 (Independence Standards Board Standard No. 1,
Independence Discussions with Audit Committees), and the Audit Committee discussed with Deloitte
the
Page 27
firms independence. The committee further considered whether the provision by Deloitte of the
non-audit services described above is compatible with maintaining the auditors independence.
Based upon the Audit Committees discussion with management and Deloitte and the Audit
Committees review of the representations of management and the disclosures by Deloitte to the
Audit Committee, the committee recommended to the Board that our audited consolidated financial
statements be included in our Annual Report on Form 10-K for the year ended June 30, 2008, for
filing with the SEC.
|
|
|
|
|
Audit Committee |
|
|
|
|
|
Christopher S. Seabrooke, Chairman |
|
|
Alasdair J. K. Pein |
|
|
Paul Edwards |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following table presents, as of October 17, 2008, information about beneficial ownership
of our common stock by:
|
|
|
each person or group of affiliated persons who or which, to our knowledge, owns
beneficially more than 5% of our outstanding shares of common stock; |
|
|
|
|
each of our directors and named executive officers; and |
|
|
|
|
all of our directors and executive officers as a group. |
Beneficial ownership of shares is determined in accordance with SEC rules and generally
includes any shares over which a person exercises sole or shared voting or investment power. The
beneficial ownership percentages set forth below are based on 58,399,595 shares of common stock
outstanding as of October 17, 2008. All shares of common stock, including that common stock
underlying stock options that are presently exercisable or exercisable within 60 days after October
17, 2008 (which we refer to as being currently exercisable) by each person are deemed to be
outstanding and beneficially owned by that person for the purpose of computing the ownership
percentage of that person, but are not considered outstanding for the purpose of computing the
percentage ownership of any other person. All our special convertible preferred stock was
automatically converted to common stock on October 8, 2008 in connection with the listing of our
common stock on the JSE Securities Exchange.
Unless otherwise indicated, to our knowledge, each person listed in the table below has sole
voting and investment power with respect to the shares shown as beneficially owned by such person,
except to the extent applicable law gives spouses shared authority. Except as otherwise noted, each
shareholders address is c/o Net 1 UEPS Technologies, Inc., President Place, 4th Floor, Corner of
Jan Smuts Avenue and Bolton Road, Rosebank, Johannesburg, South Africa.
|
|
|
|
|
|
|
|
|
|
|
Shares of Common |
|
|
|
Stock Beneficially Owned |
|
Name |
|
Number |
|
|
% |
|
Antony C. Ball(1) |
|
|
25,001 |
|
|
|
* |
|
Dr. Serge C.P Belamant(2) |
|
|
2,206,957 |
|
|
|
3.7 |
% |
Paul Edwards(3) |
|
|
11,116 |
|
|
|
* |
|
Herman G. Kotzé(4) |
|
|
237,335 |
|
|
|
* |
|
Alasdair J.K. Pein(5) |
|
|
25,001 |
|
|
|
* |
|
Page 28
|
|
|
|
|
|
|
|
|
|
|
Shares of Common |
|
|
|
Stock Beneficially Owned |
|
Name |
|
Number |
|
|
% |
|
Chris S. Seabrooke(6) |
|
|
12,310 |
|
|
|
* |
|
Brenda L. Stewart(7) |
|
|
145,002 |
|
|
|
* |
|
Nitin Soma(8) |
|
|
180,022 |
|
|
|
* |
|
Tom C Tinsley(9) |
|
|
6,409,091 |
|
|
|
11.0 |
% |
Investment entities affiliated with Brait S.A.(10) |
|
|
9,221,527 |
|
|
|
15.9 |
% |
Investment entities affiliated with General Atlantic
LLC(10) |
|
|
6,409,091 |
|
|
|
11.0 |
% |
Directors and Executive Officers as a group (11) |
|
|
9,209,633 |
|
|
|
15.9 |
% |
|
|
|
* |
|
Less than one percent |
|
(1) |
|
Represents options to purchase 25,001 shares of common stock, all of which are currently
exercisable. |
|
(2) |
|
CI Law Trustees Limited for the San Roque Trust dated 8/18/92 owns 800,799 shares of common
stock.
Dr. Serge C.P. Belamant as proxy of CI Law Trustees has the power to vote all of CI Law
Trustees shares. The remaining 1,406,158 shares are owned directly by Dr. Belamant and
include (i) 40,000 shares of restricted stock, the vesting of which is subject to the
satisfaction of certain financial performance and other conditions described elsewhere in
this proxy statement and (ii) options to purchase 32,000 shares of common stock, all of which
are currently exercisable. |
|
(3) |
|
Represents (i) options to purchase 8,335 shares of common stock, all of which are currently
exercisable, (ii) 1,351 shares of restricted stock, one-third of which vest annually commencing on
February 6, 2009 and (iii) 1,430 shares of restricted stock, one-third of which vest annually
commencing on August 27, 2009. Vesting of the restricted stock is conditioned on Mr. Edwards
continued service as a member of our Board on the applicable vesting date. |
|
(4) |
|
Includes (i) 40,000 shares of restricted stock, the vesting of which is subject to the
satisfaction of certain financial performance and other conditions described elsewhere in this
proxy statement and (ii) options to purchase 14,000 shares of common stock, all of which are
currently exercisable. |
|
(5) |
|
Includes options to purchase 16,668 shares of common stock, all of which are currently
exercisable. |
|
(6) |
|
Represents (i) options to purchase 8,335 shares of common stock, all of which are currently
exercisable, (ii) 1,931 shares of restricted stock, one-third of which vest annually commencing on
February 6, 2009 and (iii) 2,044 shares of restricted stock, one-third of which vest annually
commencing on August 27, 2009. Vesting of the restricted stock is conditioned on Mr. Seabrookes
continued service as a member of our Board on the applicable vesting date. |
|
(7) |
|
Includes (i) 35,000 shares of restricted stock, the vesting of which is subject to certain
financial performance and other conditions described elsewhere in this proxy statement and (ii)
43,336 options to purchase shares of common stock, all of which are currently exercisable. |
|
(8) |
|
Includes (i) 30,000 shares of restricted stock, the vesting of which is subject to certain
financial performance and other conditions described elsewhere in this proxy statement and (ii)
8,000 options to purchase shares of common stock, all of which are currently exercisable. |
|
(9) |
|
According to Amendment No. 1 to Schedule 13D, dated June 22, 2006, filed by General Atlantic
LLC (GA), and its affiliates, General Atlantic Partners 80, L.P. (GAP 80), General Atlantic
Partners 82, L.P.
(GAP 82), GapStar, LLC (GapStar), GAP Coinvestments III, LLC, (GAPCO III), GAP
Coinvestments IV, LLC, (GAPCO IV), GAPCO GmbH & Co. KG (KG), GAPCO Management GmbH,
(GmbH Management), and GAP Coinvestments CDA, L.P. (GAPCO CDA) and supplemental
information provided to us by GA, these entities beneficially own, in the aggregate,
6,409,091shares of common stock. GA is the general partner of GAP 80, GAP 82 and GAPCO CDA.
GA is also the sole member of GapStar. GmbH Management is the general partner of KG. The
Managing Directors of GA are Steven A. Denning (Chairman), William E. Ford Chief Executive
Officer), H. Raymond Bingham, Peter L. Bloom, Mark F. Dzialga, Klaus Esser, Vince Feng,
William O. Grabe, Abhay Havaldar, David C. Hodgson, Rene M. Kern, Jonathan Korngold,
Christopher G. Lanning, Jeff Leng, Anton J. Levy, Marc F. McMorris, Thomas J. Murphy, Matthew
Nimetz, Ranjit Pandit, Andrew C. Pearson, Raul Rai, David A. Rosenstein, |
Page 29
|
|
|
|
|
Sunish Sharma, Franchon M. Smithson, Oliver Thum, Tom C. Tinsley, Sean Tong, Philip P. Trahanas and
Florian P. Wendelstadt (collectively, the GA Managing Directors). Mr. Wendelstadt is a director
of the Company. The managing members of GAPCO III and GAPCO IV are GA Managing Directors. The
business address of each of the GA Managing Directors (other than Messrs. Esser, Feng, Leng, Tong,
Havaldar, Pandit, Rai, Sharma, Thum, Tinsley, Wendelstadt, Bingham and McMorris) is 3 Pickwick
Plaza, Greenwich, Connecticut 06830. The business address of Messrs. Esser and Thum is
Koenigsallee 62, 40212, Duesseldorf, Germany. The business address of Messrs. Feng, Leng and Tong
is Suite 2007-10, One International Finance Centre, 1 Harbour View Street, Central, Hong Kong. The
business address of Messrs. Havaldar, Pandit, Rai and Sharma is Room 151, 152 Maker Chambers VI,
Naisman Point, Mumbai 400 021, India. The business address of Messrs. Bingham and McMorris is 228
Hamilton Avenue, Palo Alto, California 94301. The business address of Mr. Tinsley is 2401
Pennsylvania Avenue NW, Washington DC 20037. |
|
(10) |
|
According to Amendment No. 2 to Schedule 13D, dated June 22, 2006, filed by South African
Private Equity Fund III, L.P., SAPEF III International G.P. Limited, Capital Partners Group
Holdings Limited and Brait, S.A., these entities beneficially own in the aggregate 9,387,984 shares
of common stock. A Form 4, dated March 25, 2008, filed by Brait S.A. reflects beneficial ownership
of 9,221,527 shares of common stock. The address and principal place of business of each of SAPEF
III Fund and SAPEF G.P. is Walker
House, P.O. Box 908, George Town, Grand Cayman, Cayman Islands. The address and principal
place of business of Capital Partners is Abbott Building, P.O. Box 3186, Road Town, Tortola,
British Virgin Islands. The address and principal place of business of Brait S.A. is 180 rue
des Aubepines, L-1145, Luxembourg. |
|
(11) |
|
Represents shares beneficially owned by the directors and executive officers listed in the
table, as well as 40,134 shares beneficially owned by Leonid Delberg and Richard Schweger, who
joined the Company and became executive officers after June 30, 2008. Includes (i) options to
purchase 97,426 shares of common stock, all of which are currently exercisable and (ii) 151,756
shares of restricted stock, the vesting of which is subject to certain conditions discussed above. |
ADDITIONAL INFORMATION
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires that our executive officers and directors, and
persons who own more than 10% of a registered class of our equity securities, file reports of
ownership and changes in ownership with the SEC and provide us with copies of such reports. We have
reviewed such reports received by us and written representations from our directors and executive
officers. Based solely on such review and representations, we believe that all filings requirements
applicable to our executive officers, directors and more than 10% shareholders were complied with
during fiscal year 2008; however we identified four filings that were not made on a timely basis.
Each of Serge Belamant, Herman Kotze, Nitin Soma and Brenda L. Stewart were late in filing one Form
4 for the receipt of restricted stock.
Other Matters
Our Board knows of no other business that will be presented for consideration at the annual
meeting. Return of a valid proxy, however, confers on the designated proxy holders discretionary
authority to vote the shares in accordance with their best judgment on such other business, if any,
that may properly come before the annual meeting or any adjournment or postponement thereof. It is
important that the proxies be returned promptly and that your shares be represented. You are urged
to sign, date and promptly return the enclosed proxy card in the enclosed envelope.
Annual Report on Form 10-K
A copy of our annual report on Form 10-K (without exhibits) for the fiscal year ended June 30,
2008 is
Page 30
being distributed along with this proxy statement. We refer you to such report for financial and
other information about us, but such report is not incorporated in this proxy statement and is not
deemed to be a part of the proxy solicitation material. It is also available on our website
(www.net1ueps.com). In addition, the report (with exhibits) is available at the SECs website
(www.sec.gov).
Shareholder Proposals for the 2009 Annual Meeting
Qualified shareholders who wish to have proposals presented at the 2009 annual meeting of
shareholders must deliver them to us by July 30, 2009, in order to be considered for inclusion in
next years proxy statement and proxy pursuant to Rule 14a-8 under the Exchange Act.
Any shareholder proposal or director nomination for our 2009 annual meeting that is submitted
outside the processes of Rule 14a-8 will be considered untimely if we receive it after July 30,
2009. Such proposals and nominations must be made in accordance with Section 2.08 of our Amended
and Restated By-Laws. An untimely proposal may be excluded from consideration at our 2009 annual
meeting. All proposals and nominations must be delivered to us at our principal executive offices
at P O Box 2424, Parklands 2121, Gauteng, South Africa.
Householding of Proxy Materials
We have adopted a procedure approved by the SEC called householding. Under this procedure,
multiple shareholders who share the same last name and address will receive only one copy of the
annual proxy materials, unless they notify us that they wish to continue receiving multiple copies.
We have undertaken householding to reduce our printing costs and postage fees.
If you wish to opt-out of householding and receive multiple copies of the proxy materials at
the same address, you may do so at any time prior to 30 days before the mailing of proxy materials,
which typically are mailed at the end of October of each year, by notifying us in writing at: Net 1
UEPS Technologies, Inc., P O Box 2424, Parklands 2121, Gauteng, South Africa, Attention: Corporate
Secretary. You also may request additional copies of the proxy materials by notifying us in writing
at the same address.
If you share an address with another shareholder and currently are receiving multiple copies
of the proxy materials, you may request householding by notifying us at the above-referenced
address.
|
|
|
|
|
|
By Order of the Board of Directors,
|
|
|
|
/s/ Dr. Serge Belamant
|
|
|
|
Dr. Serge C. P. Belamant |
|
|
|
Chairman and Chief Executive Officer |
|
|
October 29, 2008
THE BOARD HOPES THAT YOU WILL ATTEND THE MEETING. WHETHER OR NOT YOU PLAN TO ATTEND, PLEASE
PROMPTLY COMPLETE, DATE, SIGN AND RETURN THE ENCLOSED PROXY.
Page 31
Exhibit A
CERTIFICATE ACCOMPANYING
ARTICLES OF RESTATEMENT OF
ARTICLES OF INCORPORATION OF
NET 1 UEPS TECHNOLOGIES, INC.
Pursuant to the provisions of Section 607.1003 and 607.1007 of the Florida Business
Corporation Act (the Act), the undersigned corporation, NET 1 UEPS TECHNOLOGIES, INC. (the
Corporation), a Florida corporation, certifies the following:
1. The name of the Corporation is Net 1 UEPS Technologies, Inc.
2. The Articles of Restatement amend and restate the Corporations Articles of Incorporation
in their entirety.
3. The amended and restated Articles of Incorporation were adopted by the written consent of
all of the members of the Board of Directors adopted by the Board of Directors of the Corporation
effective 16, 2008.
4. The amended and restated Articles of Incorporation were recommended by the
Board of
Directors of the Corporation and submitted to the shareholders of the Corporation for approval at
the annual meeting of the shareholders of the Corporation, held on November 27, 2008. The amendment
to the Articles of Incorporation of the Corporation was approved by the shareholders of the
Corporation, with the number of votes cast for the amendment being sufficient for approval in
accordance with the applicable provisions of the Act.
IN WITNESS WHEREOF, the Chief Executive Officer of the Corporation has signed this Certificate
as of [ ], 2008.
|
|
|
|
|
|
NET 1 UEPS TECHNOLOGIES, INC.
|
|
|
By: |
|
|
|
|
Serge C.P. Belamant, |
|
|
|
Chief Executive Officer |
|
Page 32
AMENDED AND RESTATED
ARTICLES OF INCORPORATION
OF
NET 1 UEPS TECHNOLOGIES, INC.
Pursuant to Sections 607.1001, 607.1003, and 607.1007 of the Florida Business Corporation Act
(the Act), NET 1 UEPS TECHNOLOGIES, INC., approves and adopts the following Amended and Restated
Articles of Incorporation:
ARTICLE I.
Name
The name of the Corporation is Net 1 UEPS Technologies, Inc.
ARTICLE II. Term of Existence
The Corporation will have perpetual existence.
ARTICLE III.
Nature of Corporate Business and Powers
The general nature of the business to be transacted by the Corporation shall be to engage in
any and all lawful business permitted under the laws of the United States and the State of Florida.
ARTICLE IV.
Capital Stock
The maximum number of shares of capital stock that the Corporation shall be authorized to
issue and have outstanding at any one time shall be two hundred fifty million (250,000,000), of
which two hundred million (200,000,000) shares shall be designated as common stock, par value
$0.001 per share, and fifty million (50,000,000) shares shall be designated as preferred stock par
value $0.001 per share.
Series of the preferred stock may be created and issued from time to time, with such
designations, preferences, conversion rights, cumulative, relative, participating, optional or
other rights, including voting rights, qualifications, limitations or restrictions thereof as shall
be stated and expressed in the resolution or resolutions providing for the creation and issuance of
such series of preferred stock as adopted by the Board of Directors pursuant to the authority in
this paragraph given.
ARTICLE V.
Affiliated Transactions
Pursuant to Section 607.0901(5)(a) of the Act, the Corporation elects not to be governed by
the requirements or other provisions regarding affiliated transactions of Section 607.0901 of the
Act. Therefore, the terms of such section of the Act will not apply with respect to the approval,
adoption, authorization, ratification or effectuation of any affiliated transactions involving the
Corporation.
ARTICLE VI.
Amendment
These Articles of Incorporation may be amended in the manner provided by law.
IN WITNESS WHEREOF, the Chief Executive Officer of the Corporation has signed these Amended
and Restated Articles of Incorporation as of [ ] , 2008.
|
|
|
|
|
|
NET 1 UEPS TECHNOLOGIES, INC.
|
|
|
By: |
|
|
|
|
Serge C.P. Belamant, |
|
|
|
Chief Executive Officer |
|
|
Page 33
Appendix A
NET 1 UEPS TECHNOLOGIES, INC.
AUDIT COMMITTEE CHARTER
The board has resolved to establish a committee of the board to be known as the audit
committee.
1. |
|
PURPOSE |
|
|
|
The audit committee is established by the board of directors for the primary purpose of
overseeing or assisting the board in overseeing the following: |
|
|
|
The integrity of the companys financial statements. |
|
|
|
|
The companys compliance with legal and regulatory requirements. |
|
|
|
|
The qualifications and independence of the companys registered public accounting
firm (the independent auditors). |
|
|
|
|
The performance of the companys independent auditors and of the internal audit
function. |
|
|
|
|
The accounting and financial reporting processes of the company and the audits of its
financial statements. |
|
|
|
|
The companys systems of disclosure controls and procedures, internal controls over
financial reporting, and compliance with ethical standards adopted by the company. |
The committee will encourage continuous improvement of and adherence to the companys
policies, procedures and practices at all levels. The committee will also facilitate open
communication between the independent auditor, financial and senior management, the internal
audit function and the board of directors.
The audit committee has authority to obtain advice and assistance from outside legal,
accounting or other advisors as it determines necessary or appropriate to perform its duties
and responsibilities.
The company will provide appropriate funding, as determined by the committee, for
compensation to the independent auditor, to any advisors that the audit committee chooses to
engage, and for payment of ordinary administrative expenses of the committee that are
necessary or appropriate in carrying out its duties.
The committee will fulfill its responsibilities by carrying out the activities enumerated in
Section 3 of this charter. The committee will report regularly to the board of directors
regarding the execution of its duties and responsibilities and copies of audit committee
minutes will be circulated to the board.
Page 34
2. |
|
COMPOSITION AND MEETINGS |
|
2.1 |
|
The committee will comprise three or more directors as determined by the board.
The quorum for meetings of the committee will be a majority of the members of the
committee. Formal actions to be taken by the committee shall be by unanimous
written consent or by a majority of the persons present (in person or by conference
telephone) at a meeting at which a quorum is present. |
|
|
2.2 |
|
Each committee member will be a person other than an officer or employee of the company
or its subsidiaries or any other individual having a relationship which, in the opinion of
the board, would interfere with the exercise of his or her independent judgment in carrying
out the responsibilities of a director, and shall otherwise meet the independence
requirements of The NASDAQ Stock Market LLC, the Securities and Exchange Commission (the
SEC), applicable law, and any additional board guidelines. No member of the committee
shall have participated in the preparation of the financial statements of the company or any
of its subsidiaries at any time in the prior three years. |
|
|
2.3 |
|
All members of the committee must comply with the financial literacy requirements of
NASDAQ. The board will ensure that at least one member of the committee qualifies as an
audit committee financial expert in compliance with the criteria established by the SEC.
The existence of such a member, including his or her name and the fact that he or she is
independent, will be disclosed in periodic filings as required by the SEC. |
|
|
2.4 |
|
The members of the committee will be elected by the board upon the recommendation of the
Nominating and Corporate Governance Committee at the first board meeting following each
annual meeting of shareholders and will serve until the first board meeting following the
next annual meeting of shareholders and until their successors are elected and qualify. The
chairperson will be elected by the board. The board may remove any committee member with or
without cause. |
|
|
2.5 |
|
The committee will meet at least six times annually or more frequently as circumstances
dictate. Each scheduled meeting will conclude with an executive session of the committee
without members of management being present. In addition, the committee will meet
periodically in separate sessions with management, the director of the internal auditing
function and the independent auditor. The committee will also meet with the independent
auditor and management to discuss the annual audited financial statements and quarterly
financial statements, including the companys disclosures under managements discussion and
analysis of financial condition and results of operations. |
3. |
|
RESPONSIBILITIES AND DUTIES |
|
|
|
To fulfill its responsibilities and duties the audit committee will: |
Documents/Reports/Accounting Information Review
|
3.1 |
|
Review and reassess this charter at least annually, and recommend to the board of
directors any necessary amendments. |
Page 35
|
3.2 |
|
Review and discuss with management, the internal auditors, and the independent auditor the
companys annual and quarterly financial statements prior to the first public release of the
companys financial results for such year or quarter, and the companys Annual Report on Form 10-K
and Quarterly Reports on Form 10-Q in advance of such filings, and review any non-GAAP (being
accounting principles generally accepted in the United States) information included therein. Review
other relevant reports or financial information submitted by the company to any governmental body
or the public, including management certifications as required by the Sarbanes-Oxley Act of 2002
and relevant reports rendered by the independent auditor (or summaries thereof). |
|
|
3.3 |
|
Recommend to the board whether the financial statements should be included in the annual report
on Form 10-K and, if applicable, the companys Annual Report to Stockholders. |
|
|
3.4 |
|
Discuss earnings press releases prior to distribution, including the type and presentation of
information, paying particular attention to any non-GAAP information. |
|
|
3.5 |
|
Discuss financial information and earnings guidance provided to analysts and ratings agencies,
prior to distribution thereof. |
|
|
3.6 |
|
Review the regular internal reports to management (or summaries thereof) prepared by the
internal auditing department, as well as managements response. |
Independent Auditor
|
3.7 |
|
Appoint (and recommend that the board submit for shareholder ratification, if applicable) the
independent auditor. Review the performance of the independent auditor and remove it if
circumstances warrant. This committee is solely and directly responsible for the appointment,
compensation, retention, and oversight of any independent auditor engaged for the purpose of
preparing or issuing any audit report or performing other audit, review or attest services for the
company.
The independent auditor will report directly to the audit committee and the audit committee
will oversee the resolution of disagreements between management and the independent auditor
if they arise. Consider whether the auditors performance of permissible non-audit services
is compatible with the auditors independence. Discuss with the independent auditor the
matters required to be discussed under Statement on Auditing Standards No. 114, The
Auditors Communication with those Charged with Governance, as amended. |
|
|
3.8 |
|
Review with the independent auditor any problems or difficulties arising from any audit or
report or communication relating to the financial statements, and managements response and
resolution; review the independent auditors report on the companys internal controls; and hold
timely discussions with the independent auditor regarding the following: |
|
|
|
All critical accounting policies and practices. |
|
|
|
|
All alternative treatments of financial information within generally accepted
accounting principles that have been discussed with |
Page 36
|
|
|
management, ramifications of the use of such alternative disclosures and
treatments, and the treatment preferred by the independent auditor. |
|
|
|
Other material written communications between the independent auditor and
management, including, but not limited to, the management letter and schedule of
unadjusted differences. |
|
3.9 |
|
At least annually, obtain and review a report by the independent auditor describing: |
|
|
|
The firms internal quality control procedures. |
|
|
|
|
Any material issues raised by the most recent internal quality control review, peer
review, Public Company Accounting Oversight Board (PCAOB) inspection, or by any
inquiry or investigation conducted by governmental or professional authorities
during the preceding five years with respect to independent audits carried out by
the firm, and any steps taken to deal with any such issues. |
|
|
|
|
All relationships between the independent auditor and the company, addressing the
matters set forth in Independence Standards Board Standard No. 1. This report will
be used to evaluate the independent auditors qualifications, performance, and
independence. Further, the committee will review the experience and qualifications
of the lead partner and other senior members of the independent audit team each
year and determine that all partner rotation requirements, as promulgated by the
applicable rules and regulations, are executed. The committee will also consider
whether there should be rotation of the firm itself. |
|
3.10 |
|
Actively engage in dialogue with the independent auditor with respect to any disclosed
relationships or services that may affect the independence and objectivity of the auditor and take,
or recommend that the full board take, appropriate actions to ensure the independence of the
outside auditor. |
|
|
3.11 |
|
Review and pre-approve (which may be pursuant to appropriate pre-approval policies and
procedures) both audit and non-audit services to be provided by the independent auditor. The
authority to grant pre-approvals may be delegated to one or more designated members of the
committee whose decisions will be presented to the full committee at its next regularly scheduled
meeting. Such review and approval will be disclosed in reports filed with or furnished to the SEC
as required by applicable SEC regulations. |
|
|
3.12 |
|
Set clear hiring policies, compliant with governing laws and regulations, for employees or
former employees of the independent auditor. |
|
|
3.13 |
|
Obtain from the independent auditor assurance that its audit of the companys financial
statements was conducted in accordance with standards of the PCAOB. |
Financial Reporting Processes, Accounting Policies, and Internal Control Procedure
|
3.14 |
|
In consultation with the independent auditor, the internal auditor and management, review and discuss
the integrity of the companys financial |
Page 37
|
|
|
reporting processes (both internal and external), and the internal control structure
(including disclosure controls and procedures and internal control over financial
reporting). |
|
3.15 |
|
Review and discuss with management, the internal auditors, and the independent auditor the
companys report regarding internal control over financial reporting and any significant
deficiencies in the companys internal controls. |
|
|
3.16 |
|
Receive and review any disclosure from the companys CEO or CFO made in connection with the
certification of the companys quarterly and annual reports filed with the SEC of: |
|
a) |
|
all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the companys ability to record, process, summarize, and report financial data; and |
|
|
b) |
|
any fraud, whether or not material, that involves management or other employees who have
a significant role in the companys internal controls. |
|
3.17 |
|
Review major issues regarding accounting principles and financial statement presentations,
including any significant proposed or contemplated changes in the companys selection or
application of accounting principles; major issues as to the adequacy of the companys internal
controls, policies, estimates, internal controls, disclosure controls, procedures, practices or
auditing plans (including those policies for which management is required to exercise discretion)
or judgments regarding the implementation thereof and any special audit steps adopted in light of
significant control deficiencies. |
|
|
3.18 |
|
Review analyses prepared by management (and the independent auditor as noted in item 3.8
above) setting forth significant financial reporting issues and judgments made in connection with
the preparation of the financial statements, including analyses of the effects of alternative GAAP
methods on the financial statements. |
|
|
3.19 |
|
Review the effect of regulatory and accounting initiatives, as well as off-balance sheet
structures, on the financial statements of the company. |
|
|
3.20 |
|
Review and pre-approve all related party transactions, defined as those transactions or
arrangements required to be disclosed under Item 404 of Regulation S-K. |
|
|
3.21 |
|
Establish and maintain procedures for the receipt, retention, and treatment of complaints
regarding accounting, internal accounting controls, or auditing matters. |
|
|
3.22 |
|
Establish and maintain procedures for the confidential, anonymous submission by company
employees regarding questionable accounting or auditing matters. |
|
|
3.23 |
|
Periodically discuss with the independent auditor, without management being present, (a) such
firms judgments about the quality, appropriateness, and |
Page 38
|
|
|
acceptability of the companys accounting principles and financial disclosures practices, as
applied in its financial reporting, and (b) the completeness and accuracy of the companys
financial statements. |
|
3.24 |
|
Meet periodically with management, internal auditors, and/or the independent auditors to: |
|
|
|
review the annual audit plans of the independent auditors and the internal audit group;
and |
|
|
|
|
receive a detailed explanation of the accounting for any unusual or non-recurring
transactions which have a material impact on the companys financial statements during the
reporting period. |
Internal Audit
|
3.25 |
|
Review and advise on the selection and removal of the internal audit director. |
|
|
3.26 |
|
Review activities, organizational structure, and qualifications of the internal audit
function. |
|
|
3.27 |
|
Annually, review and recommend changes (if any) to the internal audit charter. |
|
|
3.28 |
|
Periodically review with the internal audit director any significant difficulties,
disagreements with management, or scope restrictions encountered in the course of the functions
work. |
Legal Compliance and Risk Management
|
3.29 |
|
Establish, review and update periodically a code of ethics applicable to all employees and
directors of the company, and determine whether management has established a system to enforce this
code. Determine whether the code is in compliance with all applicable rules and regulations.
Review and pre-approve (a) any change or waiver of this code and (b) any disclosure made on Form
8-K regarding such change or waiver. |
|
|
3.30 |
|
Review managements monitoring of the companys compliance with its code of ethics, and
determine whether management has the proper review system in place to ensure that the companys
financial statements, reports, and other financial information disseminated to governmental
organizations and the public satisfy legal requirements. |
|
|
3.31 |
|
Review, with the companys counsel, legal compliance matters, including the companys insider
trading policy, and review and approve trading plans and amendments thereto as contemplated by the
insider trading policy. |
|
|
3.32 |
|
Review, with the companys counsel, any legal matter that could have a significant impact on
the companys financial statements. |
|
|
3.33 |
|
Discuss policies with respect to risk assessment and risk management, including appropriate
guidelines and policies to govern the process, as well as the companys major financial risk
exposures and the steps management has undertaken to control them. |
Page 39
Other Responsibilities
|
3.34 |
|
Review with the independent auditor, the internal auditing department, and management the
extent to which changes or improvements in financial or accounting practices have been implemented. |
|
|
3.35 |
|
Prepare the report that the SEC requires be included in the companys annual proxy statement. |
|
|
3.36 |
|
Conduct an annual performance assessment regarding this committees purpose, duties, and
responsibilities outlined herein. |
|
|
3.37 |
|
Perform any other activities consistent with the charter, the companys bylaws, and governing
law, as the board deems necessary or appropriate. |
Page 40
Appendix B
NET 1 UEPS TECHNOLOGIES, INC.
REMUNERATION COMMITTEE
Charter
As amended on August 27, 2008
The Remuneration Committee (the Committee) of the Board of Directors (the Board) of Net 1
UEPS Technologies, Inc. (Net 1) has the responsibilities, authority and duties described in this
Charter.
Purpose
The Committee has the responsibility and authority to supervise and review the affairs of Net
1 as they relate to the compensation of executive officers, other employees, and directors of Net
1. In carrying out these responsibilities, the Committee shall review all components of executive
and director compensation for consistency with Net 1s compensation philosophy and with the
interests of Net 1s stockholders.
Composition
The Committee shall be appointed annually by the Board on the recommendation of Net 1s
Corporate Governance and Nominating Committee, and shall be comprised of at least three (3)
members, each of whom shall be independent as defined by The NASDAQ Stock Market LLC and
applicable law. In addition, at least two members of the Committee (such members, the Outside
Directors) shall also be (i) outside directors within the meaning of §162(m) (§162(m)) of the
Internal Revenue Code of 1986, as amended; and (ii) non-employee directors within the meaning of
Rule 16b-3 (Rule 16b-3) under the Securities Exchange Act of 1934, as amended. The Board shall
designate one member as Committee Chairperson, and may remove any Committee member with or without
cause. To the extent necessary to comply with §162(m) or Rule 16b-3, the Outside Directors, acting
as a subcommittee, shall have authority to act on behalf of the Committee. A director shall not
serve as a member of the Committee if any executive officer of Net 1 serves on board of directors
of another company that employs such director as an executive officer.
Meetings
The Committee shall hold meetings at least two (2) times each year, and shall hold such
additional meetings as deemed necessary or desirable by the Chairperson of the Committee and as may
be required to perform the functions described under Duties and Powers below. The Committee
should meet at least annually with Net 1s chief executive officer and such other senior executives
as the Committee deems appropriate; provided, however, that the chief executive officer may not be
present during deliberations or voting regarding his or her own compensation. The Committee should
meet periodically in executive session without the presence of management.
Duties and Powers
The following shall be the principal recurring functions of the Committee in carrying out its
responsibilities. The functions are set forth as a guide with the understanding that the Committee
may modify or supplement them as appropriate.
|
|
|
Review and approve performance goals and objectives relevant to the compensation of all
executive officers, evaluate the performance of each executive officer in light of
those goals and objectives, and set each executive officers compensation, including
incentive-based and equity-based compensation, based on such evaluation. |
Page 41
|
|
|
Make recommendations to the Board with respect to incentive and equity-based
compensation plans. |
|
|
|
|
Review and make recommendations to the Board regarding compensation-related matters
outside the ordinary course, including but not limited to employment contracts,
change-in-control provisions and severance arrangements. |
|
|
|
|
Administer Net 1s stock option, stock incentive, and other stock compensation plans
as required by Rule 16b-3, including by making and approving all grants of options and
other awards to all executive officers and directors, and all other eligible
individuals, under such plans. |
|
|
|
|
Annually review and make recommendations to the Board regarding director compensation. |
|
|
|
|
Assist management in developing and, when appropriate, recommend to the Board, the
design of compensation policies and plans. |
|
|
|
|
Review and discuss with management the disclosures in Net 1s
Compensation Discussion and Analysis and any other disclosures regarding executive
compensation to be included in Net 1s public filings or shareholder reports. |
|
|
|
|
Based upon its review and discussion with management, recommend to the Board whether the
Compensation Discussion and Analysis should be included in Net 1s proxy statement, Form
10-K, or information statement, as applicable, and prepare the related report required
by the rules of the Securities and Exchange Commission. |
|
|
|
|
Perform such other activities consistent with this Charter as the Committee or the
Board deems necessary or appropriate. |
|
|
|
|
Report to the Board on the Committees activities on a regular basis. |
Resources and Authority
The Committee shall have the resources and authority appropriate to discharge its
responsibilities, including sole authority to retain and terminate compensation consultants,
special counsel, and other experts or consultants. Net 1 shall provide for appropriate funding, as
determined by the Committee, for payment of compensation to any such advisors.
Annual Review
The Committee shall review on at least an annual basis (i) this Charter and the scope of
responsibilities of this Committee and (ii) the Committees performance of its duties. Any proposed
changes to this Charter or the Committees scope of responsibilities, where indicated, shall be
referred to the Board for appropriate action.
Operating Procedures
Formal actions to be taken by the Committee shall be by unanimous written consent or by a
majority of the persons present (in person or by conference telephone) at a meeting at which a
quorum is present. A quorum shall consist of at least 50% of the members of the Committee. Any
actions taken by the
Page 42
Committee during any period in which one or more of the members fail for any reason to meet the
membership requirements set forth above shall still constitute duly authorized actions of the
Committee for all corporate purposes.
Page 43
Appendix C
NET 1 UEPS TECHNOLOGIES, INC.
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
Charter
As amended on August 27, 2008
The Nominating and Corporate Governance Committee (the Committee) of the Board of Directors
(the Board) of Net 1 UEPS Technologies, Inc (Net 1) has the responsibilities, authority and
duties described in this Charter.
Purpose
The Committee has the responsibility and authority to supervise and review the affairs of Net
1 as they relate to Board and committee composition and leadership, Board evaluations, succession
planning, stockholder communications, and corporate governance matters.
Composition
The Committee shall be appointed annually by the Board on the recommendation of this Committee
and shall be comprised of at least three (3) directors, each of whom shall be independent as
defined by The NASDAQ Stock Market LLC and applicable law. The Board shall designate one member as
Committee Chairperson. The Board may remove Committee members with or without cause.
Meetings
The Committee shall hold meetings at least two (2) times each year, and shall hold such
additional meetings as deemed necessary or desirable by the Chairperson of the Committee and as may
be required to perform the functions described under Duties and Powers below. The Committee may,
at its discretion, meet in executive session with or without the presence of management.
Duties and Powers
The following shall be the principal recurring functions of the Committee in carrying out its
responsibilities. The functions are set forth as a guide with the understanding that the Committee
may modify or supplement them as appropriate.
|
|
|
Monitor the composition, size and independence of the Board and recommend changes to
the Board as appropriate. |
|
|
|
|
Review periodically the continued appropriateness of Board membership for each
director, including upon a change in a directors employment or other relevant
circumstances. |
|
|
|
|
Develop and recommend to the Board the appropriate skills and characteristics
required of directors, as well as any additional qualifications appropriate for any
one or more directors, based on the needs of Net 1 from time to time, and confer
with the full Board as to the application of these criteria in connection with
identifying new Board candidates. |
|
|
|
|
Seek out appropriate, qualified candidates to serve as directors of Net 1 and
encourage and receive recommendations for director candidates from all sources. |
Page 44
|
|
|
Monitor Net 1s procedures for the receipt and consideration of director
nominations by stockholders and other persons. |
|
|
|
|
Interview and otherwise examine director candidates and their credentials. |
|
|
|
|
Recommend to the Board candidates for nomination as directors except that if Net 1
is at any time legally required by contract or otherwise to provide any third party
with the ability to nominate a director, the Committee need not evaluate or
recommend such nomination unless required to do so by contract or requested to do so
by the Board. |
|
|
|
|
Perform such other advisory functions with respect to the selection and nomination
of directors of Net 1 as are deemed appropriate by the members of the Committee. |
|
|
|
|
Recommend to the Board the annual assignment of directors to Board committees and
the nomination of committee chairpersons. |
|
|
|
|
Review Net 1s Corporate Governance Guidelines annually and recommend changes, as
appropriate, for review and approval by the Board. |
|
|
|
|
Monitor Net 1s compliance with governance obligations and best practices and
recommend changes for review and approval by the full Board. |
|
|
|
|
Establish and monitor procedures by which the Board will conduct, at least annually,
evaluations of its performance. |
|
|
|
|
Establish and monitor procedures for the receipt of stockholder communications
directed to the Board. |
|
|
|
|
Prepare or review disclosure regarding the Committees duties required to be
included in Net 1s annual proxy statement. |
|
|
|
|
Review and make recommendations to the Board regarding proposals submitted by
stockholders for presentation at a stockholder meeting. |
|
|
|
|
Develop and implement director orientation and continuing education programs. |
|
|
|
|
Oversee an annual review by the Board on succession planning, including
transitional leadership for unplanned vacancies. |
|
|
|
|
Report to the Board on the Committees activities on a regular basis. |
Resources and Authority
The Committee shall have the resources and authority appropriate to discharge its
responsibilities, including sole authority to retain and terminate search firms, special counsel
and other experts or consultants. Net 1 shall provide for appropriate funding, as determined by the
Committee, for payment of compensation to any such advisors.
Page 45
Annual Review
The Committee shall review on at least an annual basis (i) this Charter and the scope of
responsibilities of this Committee and (ii) the Committees performance of its duties. Any proposed
changes to this Charter or the Committees scope of responsibilities, where indicated, shall be
referred to the Board for appropriate action.
Operating Procedures
Formal actions to be taken by the Committee shall be by unanimous written consent or by a
majority of the persons present (in person or by conference telephone) at a meeting at which a
quorum is present. A quorum shall consist of at least 50% of the members of the Committee. Any
actions taken by the Committee during any period in which one or more of the members fail for any
reason to meet the membership requirements set forth above shall still constitute duly authorized
actions of the Committee for all corporate purposes.
Page 46
NET 1 UEPS TECHNOLOGIES, INC.
PROXY
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
This proxy is solicited on behalf of the Board of Directors of Net 1 UEPS Technologies, Inc.
for the Annual Meeting of Shareholders to be held on November 27, 2008. The undersigned, appoints
Dr. Serge C.P. Belamant and Herman G. Kotze, and each of them, with full power of substitution in
each, the proxies of the undersigned, to represent the undersigned and vote all shares of the
common stock of Net 1 UEPS Technologies, Inc. which the undersigned may be entitled to vote at the
Annual Meeting of Shareholders to be held on November 27, 2008, and at any adjournment or
postponement thereof, as indicated on the reverse side of this proxy.
This proxy, when properly executed, will be voted in the manner directed herein by the
undersigned shareholder. If no direction is given, then this proxy will be voted FOR ALL nominees
for director and FOR proposals 2 and 3.
|
|
|
|
|
|
|
Address Change |
|
|
|
|
|
|
Net 1 UEPS Technologies, Inc. |
|
|
|
|
|
|
|
|
|
P.O. BOX 11057 |
|
|
|
|
|
|
|
|
|
NEW YORK, N.Y. 10203-0057 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
▼ DETACH PROXY CARD HERE ▼
|
|
|
|
|
|
|
|
|
Mark, Sign, Date and Return this Proxy Card Promptly
Using the Enclosed Envelope. |
|
x
Votes must be indicated (x) in Black or Blue ink. |
|
|
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED
SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR ALL NOMINEES FOR DIRECTOR AND
FOR PROPOSALS 2, 3 AND 4.
1. |
|
ELECTION OF DIRECTORS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
ALL |
|
|
|
WITHHOLD FOR ALL |
|
c |
|
EXCEPTIONS |
|
c |
|
To change your address, please mark this box and
provide new address where indicated on the reverse
side of this Proxy Card. |
|
c |
|
|
|
|
|
|
|
Nominees: |
|
Dr. Serge C.P. Belamant, Herman G. Kotze, Christopher S. Seabrooke,
Antony C. Ball, Alasdair J.K. Pein, Paul Edwards and Tom C.
Tinsley |
|
To include any comments, please mark this box. |
|
c |
|
|
|
|
|
|
|
INSTRUCTION: To withhold authority to vote for any individual
nominee, write that nominees name in the
following space: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
PROPOSAL TO APPROVE THE AMENDED AND RESTATED
ARTICLES OF INCORPORATION. |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
|
PROPOSAL TO RATIFY THE SELECTION OF DELOITTE &
TOUCHE (SOUTH AFRICA) AS THE INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM FOR THE
COMPANY FOR THE 2009 FISCAL YEAR. |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4. |
|
In their discretion upon such other matters as may properly come before the
meeting. |
|
S C A N L I N E
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please sign exactly as your name appears on your stock certificates. When joint tenants hold
shares, both
should sign. When signing as attorney, executor, administrator,
trustee, guardian, please give full title as such. If a
corporation, please sign in full corporate name by president or
other authorized officer. If a partnership, please sign in
partnership name by authorized person. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholder sign here
|
|
Co-Owner sign here
|
|
Date |